Stephen J. Kish - Publications

Affiliations: 
University of Toronto, Toronto, ON, Canada 
Area:
Neuroscience Biology

209/329 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Tong J, Meyer JH, Boileau I, Ang LC, Fletcher PJ, Furukawa Y, Kish SJ. Serotonin transporter protein in autopsied brain of chronic users of cocaine. Psychopharmacology. PMID 32494974 DOI: 10.1007/S00213-020-05562-4  0.366
2020 Rathitharan G, Truong J, Tong J, McCluskey T, Meyer JH, Mizrahi R, Warsh J, Rusjan P, Kennedy JL, Houle S, Kish SJ, Boileau I. Microglia imaging in methamphetamine use disorder: a positron emission tomography study with the 18 kDa translocator protein radioligand [F-18]FEPPA. Addiction Biology. e12876. PMID 32017280 DOI: 10.1111/Adb.12876  0.371
2020 Best LM, Williams B, Le Foll B, Mansouri E, Bazinet RP, Lin L, De Luca V, Lagzdins D, Rusjan P, Tyndale RF, Wilson AA, Hendershot CS, Heilig M, Houle S, Tong J, ... Kish SJ, et al. Lower brain fatty acid amide hydrolase in treatment-seeking patients with alcohol use disorder: a positron emission tomography study with [C-11]CURB. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31910433 DOI: 10.1038/S41386-020-0606-2  0.356
2020 Truong J, Best LM, McCluskey T, Tong J, Rusjan PM, Meyer JH, Le Foll B, Hendershot CS, Rubin-Kahana DS, Warsh J, Houle S, Kish SJ, Boileau I. Investigating Brain Monoamine Oxidase B Status in Alcohol Use Disorder With the Positron Emission Tomography (PET) Tracer [C-11]SL25.1188 Biological Psychiatry. 87: S407. DOI: 10.1016/J.Biopsych.2020.02.1203  0.304
2019 Mansouri E, Nobrega JN, Hill MN, Tyndale RF, Lee FS, Hendershot CS, Best LM, Di Ciano P, Balsevich G, Sloan ME, Kish SJ, Tong J, Le Foll B, Boileau I. D3 dopamine receptors and a missense mutation of fatty acid amide hydrolase linked in mouse and men: implication for addiction. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31775159 DOI: 10.1038/S41386-019-0580-8  0.36
2019 Tong J, Williams B, Rusjan PM, Mizrahi R, Lacapère JJ, McCluskey T, Furukawa Y, Guttman M, Ang LC, Boileau I, Meyer JH, Kish SJ. Concentration, distribution, and influence of aging on the 18 kDa translocator protein in human brain: Implications for brain imaging studies. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X19858003. PMID 31220997 DOI: 10.1177/0271678X19858003  0.369
2019 Moriguchi S, Wilson AA, Miler L, Rusjan PM, Vasdev N, Kish SJ, Rajkowska G, Wang J, Bagby M, Mizrahi R, Varughese B, Houle S, Meyer JH. Monoamine Oxidase B Total Distribution Volume in the Prefrontal Cortex of Major Depressive Disorder: An [11C]SL25.1188 Positron Emission Tomography Study. Jama Psychiatry. PMID 30840042 DOI: 10.1001/Jamapsychiatry.2019.0044  0.313
2019 Mansouri E, Tyndale RF, Hendershot CS, Best LM, Di Ciano P, Hill M, Nobrega JJ, Sloan M, Kish S, Tong J, Le Foll B, Boileau I. S203. Fatty Acid Amide Hydrolase Polymorphism C385A Associated With Dopamine D2/3 Receptor Levels: A PET Study With [11C]-(+)-PHNO Biological Psychiatry. 85: S376. DOI: 10.1016/J.Biopsych.2019.03.954  0.311
2018 Tong J, Fitzmaurice PS, Moszczynska A, Rathitharan G, Ang LC, Meyer JH, Mizrahi R, Boileau I, Furukawa Y, McCluskey T, Sailasuta N, Kish SJ. Normal glutathione levels in autopsied brain of chronic users of heroin and of cocaine. Drug and Alcohol Dependence. 190: 20-28. PMID 29960919 DOI: 10.1016/J.Drugalcdep.2018.05.021  0.679
2018 Matthews BA, Tong J, Attwells S, Xu X, Le A, Kish SJ, Meyer JH. Elevated monoamine oxidase A activity and protein levels in rodent brain during acute withdrawal after chronic intermittent ethanol vapor exposure. Drug and Alcohol Dependence. 185: 398-405. PMID 29549852 DOI: 10.1016/J.Drugalcdep.2017.11.036  0.319
2017 Tong J, Rathitharan G, Meyer JH, Furukawa Y, Ang LC, Boileau I, Guttman M, Hornykiewicz O, Kish SJ. Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders. Brain : a Journal of Neurology. 140: 2460-2474. PMID 29050386 DOI: 10.1093/Brain/Awx172  0.466
2017 Attwells S, Setiawan E, Wilson AA, Rusjan PM, Mizrahi R, Miler L, Xu C, Richter MA, Kahn A, Kish SJ, Houle S, Ravindran L, Meyer JH. Inflammation in the Neurocircuitry of Obsessive-Compulsive Disorder. Jama Psychiatry. PMID 28636705 DOI: 10.1001/Jamapsychiatry.2017.1567  0.338
2017 Raitsin S, Tong J, Kish S, Xu X, Magomedova L, Cummins C, Andreazza AC, Scola G, Baker G, Meyer JH. Subchronic Glucocorticoids, Glutathione Depletion and a Postpartum Model Elevate Monoamine Oxidase A Activity in the Prefrontal Cortex of Rats. Brain Research. PMID 28435083 DOI: 10.1016/J.Brainres.2017.03.032  0.347
2017 Furukawa Y, Hornykiewicz O, Kish S. Characteristic neurochemical changes in the substantia nigra (SN) and striatum of symptomatic versus asymptomatic dopa-responsive dystonia (DRD) Journal of the Neurological Sciences. 381: 178. DOI: 10.1016/J.Jns.2017.08.515  0.322
2016 Payer D, Williams B, Mansouri E, Stevanovski S, Nakajima S, Le Foll B, Kish S, Houle S, Mizrahi R, George SR, George TP, Boileau I. Corticotropin-releasing hormone and dopamine release in healthy individuals. Psychoneuroendocrinology. 76: 192-196. PMID 27951520 DOI: 10.1016/J.Psyneuen.2016.11.034  0.34
2016 Sitte HH, Pifl C, Rajput AH, Hörtnagl H, Tong J, Lloyd GK, Kish SJ, Hornykiewicz O. Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: Possible functional implications. The European Journal of Neuroscience. PMID 27741357 DOI: 10.1111/Ejn.13435  0.435
2016 Tong J, Mizrahi R, Houle S, Kish SJ, Boileau I, Nobrega J, Rusjan PM, Wilson AA. Inhibition of fatty acid amide hydrolase by BIA 10-2474 in rat brain. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 27650910 DOI: 10.1177/0271678X16668890  0.347
2016 Kish SJ, Boileau I, Callaghan RC, Tong J. Brain dopamine neurone "damage": methamphetamine users vs. parkinson's disease ─ A critical assessment of the evidence. The European Journal of Neuroscience. PMID 27519465 DOI: 10.1111/Ejn.13363  0.437
2016 Furukawa Y, Rajput AH, Tong J, Tomizawa Y, Hornykiewicz O, Kish SJ. A marked contrast between serotonergic and dopaminergic changes in dopa-responsive dystonia. Neurology. PMID 27488599 DOI: 10.1212/Wnl.0000000000003065  0.41
2016 Boileau I, Payer D, Rusjan PM, Houle S, Tong J, McCluskey T, Wilson AA, Kish SJ. Heightened Dopaminergic Response to Amphetamine at the D3 Dopamine Receptor in Methamphetamine Users. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27353309 DOI: 10.1038/Npp.2016.108  0.375
2016 Boileau I, Mansouri E, Williams B, Le Foll B, Rusjan P, Mizrahi R, Tyndale RF, Huestis MA, Payer DE, Wilson AA, Houle S, Kish SJ, Tong J. Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [(11)C]CURB. Biological Psychiatry. PMID 27345297 DOI: 10.1016/J.Biopsych.2016.04.012  0.369
2016 Tong J, Fitzmaurice PS, Moszczynska A, Mattina K, Ang LC, Boileau I, Furukawa Y, Sailasuta N, Kish SJ. Do glutathione levels decline in aging human brain? Free Radical Biology & Medicine. PMID 26845616 DOI: 10.1016/J.Freeradbiomed.2016.01.029  0.696
2015 Payer DE, Guttman M, Kish SJ, Tong J, Adams JR, Rusjan P, Houle S, Furukawa Y, Wilson AA, Boileau I. D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia. Neurology. PMID 26718579 DOI: 10.1212/Wnl.0000000000002285  0.331
2015 Boileau I, McCluskey T, Tong J, Furukawa Y, Houle S, Kish SJ. Rapid Recovery of Vesicular Dopamine Levels in Methamphetamine Users in Early Abstinence. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26321315 DOI: 10.1038/Npp.2015.267  0.396
2015 Tong J, Ang LC, Williams B, Furukawa Y, Fitzmaurice P, Guttman M, Boileau I, Hornykiewicz O, Kish SJ. Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation. Neurobiology of Disease. 82: 243-253. PMID 26102022 DOI: 10.1016/J.Nbd.2015.06.010  0.365
2015 Boileau I, Rusjan PM, Williams B, Mansouri E, Mizrahi R, De Luca V, Johnson DS, Wilson AA, Houle S, Kish SJ, Tong J. Blocking of fatty acid amide hydrolase activity with PF-04457845 in human brain: a positron emission tomography study with the novel radioligand [(11)C]CURB. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 26082009 DOI: 10.1038/Jcbfm.2015.133  0.344
2015 Boileau I, Tyndale RF, Williams B, Mansouri E, Westwood DJ, Foll BL, Rusjan PM, Mizrahi R, De Luca V, Zhou Q, Wilson AA, Houle S, Kish SJ, Tong J. The fatty acid amide hydrolase C385A variant affects brain binding of the positron emission tomography tracer [(11)C]CURB. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 26036940 DOI: 10.1038/Jcbfm.2015.119  0.305
2015 Payer DE, Guttman M, Kish SJ, Tong J, Strafella A, Zack M, Adams JR, Rusjan P, Houle S, Furukawa Y, Wilson AA, Boileau I. [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 160-6. PMID 25641350 DOI: 10.1002/Mds.26135  0.386
2015 Furukawa Y, Kish SJ. Parkinsonism in GTP cyclohydrolase 1-deficient DOPA-responsive dystonia Brain. 138: e351. PMID 25416181 DOI: 10.1093/Brain/Awu325  0.32
2015 Payer D, Park MT, Kish S, Lerch J, Boileau I, Chakravarty MM. Exploring brain morphology in poly-stimulant abuse: shape, volume, and surface area abnormalities in Ecstasy-cocaine- and methamphetamine-preferring individuals Drug and Alcohol Dependence. 146: e65. DOI: 10.1016/J.Drugalcdep.2014.09.546  0.321
2014 Tong J, Fitzmaurice P, Furukawa Y, Schmunk GA, Wickham DJ, Ang LC, Sherwin A, McCluskey T, Boileau I, Kish SJ. Is brain gliosis a characteristic of chronic methamphetamine use in the human? Neurobiology of Disease. 67: 107-18. PMID 24704312 DOI: 10.1016/J.Nbd.2014.03.015  0.408
2014 Boileau I, Payer D, Chugani B, Lobo DS, Houle S, Wilson AA, Warsh J, Kish SJ, Zack M. In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [(11)C]-(+)-PHNO. Molecular Psychiatry. 19: 1305-13. PMID 24322203 DOI: 10.1038/Mp.2013.163  0.355
2013 Tong J, Meyer JH, Furukawa Y, Boileau I, Chang LJ, Wilson AA, Houle S, Kish SJ. Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 33: 863-71. PMID 23403377 DOI: 10.1038/Jcbfm.2013.19  0.34
2013 Boileau I, Payer D, Chugani B, Lobo D, Behzadi A, Rusjan PM, Houle S, Wilson AA, Warsh J, Kish SJ, Zack M. The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride. Addiction (Abingdon, England). 108: 953-63. PMID 23167711 DOI: 10.1111/Add.12066  0.333
2012 Pifl C, Kish SJ, Hornykiewicz O. Thalamic noradrenaline in Parkinson's disease: deficits suggest role in motor and non-motor symptoms. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1618-24. PMID 23038412 DOI: 10.1002/Mds.25109  0.32
2012 Boileau I, Payer D, Houle S, Behzadi A, Rusjan PM, Tong J, Wilkins D, Selby P, George TP, Zack M, Furukawa Y, McCluskey T, Wilson AA, Kish SJ. Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 1353-9. PMID 22279219 DOI: 10.1523/Jneurosci.4371-11.2012  0.365
2012 Sacher J, Rabiner EA, Clark M, Rusjan P, Soliman A, Boskovic R, Kish SJ, Wilson AA, Houle S, Meyer JH. Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [(11)C]-harmine positron emission tomography study. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 443-6. PMID 22186668 DOI: 10.1038/Jcbfm.2011.184  0.342
2012 Mann A, Miksys SL, Gaedigk A, Kish SJ, Mash DC, Tyndale RF. The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients. Neurobiology of Aging. 33: 2160-71. PMID 21958961 DOI: 10.1016/J.Neurobiolaging.2011.08.014  0.346
2012 Callaghan RC, Cunningham JK, Sykes J, Kish SJ. Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. Drug and Alcohol Dependence. 120: 35-40. PMID 21794992 DOI: 10.1016/J.Drugalcdep.2011.06.013  0.358
2011 Tong J, Boileau I, Furukawa Y, Chang LJ, Wilson AA, Houle S, Kish SJ. Distribution of vesicular monoamine transporter 2 protein in human brain: implications for brain imaging studies. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 31: 2065-75. PMID 21522164 DOI: 10.1038/Jcbfm.2011.63  0.414
2011 Tong J, Furukawa Y, Sherwin A, Hornykiewicz O, Kish SJ. Heterogeneous intrastriatal pattern of proteins regulating axon growth in normal adult human brain. Neurobiology of Disease. 41: 458-68. PMID 21029775 DOI: 10.1016/J.Nbd.2010.10.017  0.373
2010 Callaghan RC, Cunningham JK, Sajeev G, Kish SJ. Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2333-9. PMID 20737543 DOI: 10.1002/Mds.23263  0.33
2010 Kish SJ, Lerch J, Furukawa Y, Tong J, McCluskey T, Wilkins D, Houle S, Meyer J, Mundo E, Wilson AA, Rusjan PM, Saint-Cyr JA, Guttman M, Collins DL, Shapiro C, et al. Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study. Brain : a Journal of Neurology. 133: 1779-97. PMID 20483717 DOI: 10.1093/Brain/Awq103  0.399
2010 Boileau I, Houle S, Rusjan PM, Furukawa Y, Wilkins D, Tong J, Selby P, Wilson AA, Kish SJ. Influence of a low dose of amphetamine on vesicular monoamine transporter binding: a PET (+)[11C]DTBZ study in humans. Synapse (New York, N.Y.). 64: 417-20. PMID 20169578 DOI: 10.1002/Syn.20743  0.311
2010 Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O, Furukawa Y. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. Brain : a Journal of Neurology. 133: 172-88. PMID 19903734 DOI: 10.1093/Brain/Awp282  0.326
2010 Kish SJ, Fitzmaurice PS, Chang LJ, Furukawa Y, Tong J. Low striatal serotonin transporter protein in a human polydrug MDMA (ecstasy) user: a case study. Journal of Psychopharmacology (Oxford, England). 24: 281-4. PMID 18832433 DOI: 10.1177/0269881108097724  0.407
2010 Boileau I, Guttman M, Adams JR, Houle S, Tong J, Rusjan P, Wilson A, Kapur S, Kish SJ. Parkinson's disease, impulse control disorder and the D3 dopamine receptor system: Preliminary PET imaging studies with [11C](+)PHNO comparison with [11C]racloride Neuroimage. 52: S84. DOI: 10.1016/J.Neuroimage.2010.04.067  0.332
2009 Roedding AS, Gao AF, Wu AM, Li PP, Kish SJ, Warsh JJ. TRPC3 protein is expressed across the lifespan in human prefrontal cortex and cerebellum. Brain Research. 1260: 1-6. PMID 19168035 DOI: 10.1016/J.Brainres.2008.12.069  0.345
2009 Boileau I, Guttman M, Rusjan P, Adams JR, Houle S, Tong J, Hornykiewicz O, Furukawa Y, Wilson AA, Kapur S, Kish SJ. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease. Brain : a Journal of Neurology. 132: 1366-75. PMID 19153147 DOI: 10.1093/Brain/Awn337  0.354
2009 Kish SJ, Fitzmaurice PS, Boileau I, Schmunk GA, Ang LC, Furukawa Y, Chang LJ, Wickham DJ, Sherwin A, Tong J. Brain serotonin transporter in human methamphetamine users. Psychopharmacology. 202: 649-61. PMID 18841348 DOI: 10.1007/S00213-008-1346-X  0.395
2009 Kish S, McCluskey T, Meyer J, Warsh J, Wilkins D, Wilson A, Houle S. Serotonin Transporter Concentration is Decreased in Cerebral Cortex but not in Striatum of Chronic MDMA (ecstasy) Users European Psychiatry. 24: 1-1. DOI: 10.1016/S0924-9338(09)70667-4  0.422
2008 Boileau I, Rusjan P, Houle S, Wilkins D, Tong J, Selby P, Guttman M, Saint-Cyr JA, Wilson AA, Kish SJ. Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker? The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 9850-6. PMID 18815269 DOI: 10.1523/Jneurosci.3008-08.2008  0.388
2008 Tong J, Wilson AA, Boileau I, Houle S, Kish SJ. Dopamine modulating drugs influence striatal (+)-[11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration. Synapse (New York, N.Y.). 62: 873-6. PMID 18720517 DOI: 10.1002/Syn.20573  0.356
2008 Boileau I, Warsh JJ, Guttman M, Saint-Cyr JA, McCluskey T, Rusjan P, Houle S, Wilson AA, Meyer JH, Kish SJ. Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1776-80. PMID 18661545 DOI: 10.1002/Mds.22212  0.305
2008 Kish SJ. Pharmacologic mechanisms of crystal meth. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 178: 1679-82. PMID 18559805 DOI: 10.1503/Cmaj.071675  0.419
2008 Frankel PS, Alburges ME, Bush L, Hanson GR, Kish SJ. Striatal and ventral pallidum dynorphin concentrations are markedly increased in human chronic cocaine users. Neuropharmacology. 55: 41-6. PMID 18538358 DOI: 10.1016/J.Neuropharm.2008.04.019  0.41
2008 Kish SJ, Tong J, Hornykiewicz O, Rajput A, Chang LJ, Guttman M, Furukawa Y. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease. Brain : a Journal of Neurology. 131: 120-31. PMID 17956909 DOI: 10.1093/Brain/Awm239  0.425
2007 Frankel PS, Alburges ME, Bush L, Hanson GR, Kish SJ. Brain levels of neuropeptides in human chronic methamphetamine users. Neuropharmacology. 53: 447-54. PMID 17688891 DOI: 10.1016/J.Neuropharm.2007.06.009  0.461
2007 Tong J, Hornykiewicz O, Furukawa Y, Kish SJ. Marked dissociation between high noradrenaline versus low noradrenaline transporter levels in human nucleus accumbens. Journal of Neurochemistry. 102: 1691-702. PMID 17484728 DOI: 10.1111/J.1471-4159.2007.04636.X  0.404
2007 Guttman M, Boileau I, Warsh J, Saint-Cyr JA, Ginovart N, McCluskey T, Houle S, Wilson A, Mundo E, Rusjan P, Meyer J, Kish SJ. Brain serotonin transporter binding in non-depressed patients with Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 14: 523-8. PMID 17437611 DOI: 10.1111/J.1468-1331.2007.01727.X  0.393
2006 Tong J, Hornykiewicz O, Kish SJ. Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline. Archives of Neurology. 63: 1724-8. PMID 17172611 DOI: 10.1001/Archneur.63.12.1724  0.412
2006 Fitzmaurice PS, Tong J, Yazdanpanah M, Liu PP, Kalasinsky KS, Kish SJ. Levels of 4-hydroxynonenal and malondialdehyde are increased in brain of human chronic users of methamphetamine. The Journal of Pharmacology and Experimental Therapeutics. 319: 703-9. PMID 16857724 DOI: 10.1124/Jpet.106.109173  0.464
2006 Ross BM, Hughes B, Kish SJ, Warsh JJ. Serum calcium-independent phospholipase A2 activity in bipolar affective disorder. Bipolar Disorders. 8: 265-70. PMID 16696828 DOI: 10.1111/J.1399-5618.2006.00299.X  0.316
2006 Tong J, Hornykiewicz O, Kish SJ. Identification of a noradrenaline-rich subdivision of the human nucleus accumbens. Journal of Neurochemistry. 96: 349-54. PMID 16336226 DOI: 10.1111/J.1471-4159.2005.03546.X  0.412
2005 Kish SJ, Furukawa Y, Chang LJ, Tong J, Ginovart N, Wilson A, Houle S, Meyer JH. Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region? Nuclear Medicine and Biology. 32: 123-8. PMID 15721757 DOI: 10.1016/J.Nucmedbio.2004.10.001  0.395
2005 Furukawa Y, Guttman M, Nakamura S, Kish SJ. Dopa-Responsive Dystonia Rinshō Shinkeigaku Clinical Neurology. 46: 209-229. DOI: 10.1007/978-1-60761-835-5_24  0.313
2004 Mirecki A, Fitzmaurice P, Ang L, Kalasinsky KS, Peretti FJ, Aiken SS, Wickham DJ, Sherwin A, Nobrega JN, Forman HJ, Kish SJ. Brain antioxidant systems in human methamphetamine users. Journal of Neurochemistry. 89: 1396-408. PMID 15189342 DOI: 10.1111/J.1471-4159.2004.02434.X  0.432
2004 Siegal D, Erickson J, Varoqui H, Ang L, Kalasinsky KS, Peretti FJ, Aiken SS, Wickham DJ, Kish SJ. Brain vesicular acetylcholine transporter in human users of drugs of abuse. Synapse (New York, N.Y.). 52: 223-32. PMID 15103689 DOI: 10.1002/Syn.20020  0.426
2004 Tong J, Fitzmaurice PS, Ang LC, Furukawa Y, Guttman M, Kish SJ. Brain dopamine-stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Annals of Neurology. 55: 125-9. PMID 14705122 DOI: 10.1002/Ana.10814  0.411
2004 Moszczynska A, Fitzmaurice P, Ang L, Kalasinsky KS, Schmunk GA, Peretti FJ, Aiken SS, Wickham DJ, Kish SJ. Why is parkinsonism not a feature of human methamphetamine users? Brain : a Journal of Neurology. 127: 363-70. PMID 14645148 DOI: 10.1093/Brain/Awh046  0.71
2003 Kish SJ. What is the evidence that Ecstasy (MDMA) can cause Parkinson's disease? Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1219-23. PMID 14639660 DOI: 10.1002/Mds.10643  0.347
2003 Haycock JW, Becker L, Ang L, Furukawa Y, Hornykiewicz O, Kish SJ. Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum. Journal of Neurochemistry. 87: 574-85. PMID 14535941 DOI: 10.1046/J.1471-4159.2003.02017.X  0.374
2003 Fitzmaurice PS, Ang L, Guttman M, Rajput AH, Furukawa Y, Kish SJ. Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 969-76. PMID 14502663 DOI: 10.1002/Mds.10486  0.349
2003 Andreopoulos S, Li PP, Siu KP, Kish SJ, Warsh JJ. Altered CTX-catalyzed and endogenous [32P]ADP-ribosylation of stimulatory G protein alphas isoforms in postmortem bipolar affective disorder temporal cortex. Journal of Neuroscience Research. 72: 638-45. PMID 12749029 DOI: 10.1002/Jnr.10620  0.302
2003 Tong J, Ross BM, Schmunk GA, Peretti FJ, Kalasinsky KS, Furukawa Y, Ang LC, Aiken SS, Wickham DJ, Kish SJ. Decreased striatal dopamine D1 receptor-stimulated adenylyl cyclase activity in human methamphetamine users. The American Journal of Psychiatry. 160: 896-903. PMID 12727693 DOI: 10.1176/Appi.Ajp.160.5.896  0.393
2002 Swerdlow RH, Kish SJ. Mitochondria in Alzheimer's disease. International Review of Neurobiology. 53: 341-85. PMID 12512346 DOI: 10.1016/S0074-7742(02)53013-0  0.304
2002 Furukawa Y, Kapatos G, Haycock JW, Worsley J, Wong H, Kish SJ, Nygaard TG. Brain biopterin and tyrosine hydroxylase in asymptomatic dopa-responsive dystonia. Annals of Neurology. 51: 637-41. PMID 12112113 DOI: 10.1002/Ana.10175  0.413
2002 Furukawa Y, Vigouroux S, Wong H, Guttman M, Rajput AH, Ang L, Briand M, Kish SJ, Briand Y. Brain proteasomal function in sporadic Parkinson's disease and related disorders. Annals of Neurology. 51: 779-82. PMID 12112087 DOI: 10.1002/Ana.10207  0.411
2002 Fitzmaurice PS, Bamsey CL, Ang L, Guttman M, Rajput AH, Furukawa Y, Kish SJ. Brain aconitase activity is not decreased in progressive supranuclear palsy Neurology. 59: 137-138. PMID 12105325 DOI: 10.1212/Wnl.59.1.137  0.421
2002 Ross BM, Moszczynska A, Peretti FJ, Adams V, Schmunk GA, Kalasinsky KS, Ang L, Mamalias N, Turenne SD, Kish SJ. Decreased activity of brain phospholipid metabolic enzymes in human users of cocaine and methamphetamine. Drug and Alcohol Dependence. 67: 73-9. PMID 12062780 DOI: 10.1016/S0376-8716(02)00022-4  0.7
2002 Kish SJ. How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy? Pharmacology, Biochemistry, and Behavior. 71: 845-55. PMID 11888575 DOI: 10.1016/S0091-3057(01)00708-0  0.394
2001 Tong J, Ross BM, Sherwin AL, Kish SJ. Dopamine D1-stimulated adenylyl cyclase activity in cerebral cortex of autopsied human brain. Neurochemistry International. 39: 117-25. PMID 11408090 DOI: 10.1016/S0197-0186(01)00016-X  0.433
2001 Kish SJ, Kalasinsky KS, Schmunk G, Furukawa Y, Guttman M, Ang L. Dopaminergic changes in human brain following acute exposure to γ-hydroxybutyrate Neurology. 56: 1602-1603. PMID 11402130 DOI: 10.1212/Wnl.56.11.1602  0.401
2001 Guttman M, Stewart D, Hussey D, Wilson A, Houle S, Kish S. Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD. Neurology. 56: 1559-64. PMID 11402115 DOI: 10.1212/Wnl.56.11.1559  0.342
2001 Kalasinsky KS, Dixon MM, Schmunk GA, Kish SJ. Blood, brain, and hair GHB concentrations following fatal ingestion Journal of Forensic Sciences. 46: 728-730. PMID 11373018 DOI: 10.1520/Jfs15032J  0.324
2001 Kish SJ, Kalasinsky KS, Derkach P, Schmunk GA, Guttman M, Ang L, Adams V, Furukawa Y, Haycock JW. Striatal dopaminergic and serotonergic markers in human heroin users Neuropsychopharmacology. 24: 561-567. PMID 11282256 DOI: 10.1016/S0893-133X(00)00209-8  0.425
2001 Kalasinsky KS, Bosy TZ, Schmunk GA, Reiber G, Anthony RM, Furukawa Y, Guttman M, Kish SJ. Regional distribution of methamphetamine in autopsied brain of chronic human methamphetamine users Forensic Science International. 116: 163-169. PMID 11182268 DOI: 10.1016/S0379-0738(00)00368-6  0.427
2001 Ross BM, Mamalias N, Moszczynska A, Rajput AH, Kish SJ. Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease. Neuroscience. 102: 899-904. PMID 11182251 DOI: 10.1016/S0306-4522(00)00501-7  0.711
2000 Worsley JN, Moszczynska A, Falardeau P, Kalasinsky KS, Schmunk G, Guttman M, Furukawa Y, Ang L, Adams V, Reiber G, Anthony RA, Wickham D, Kish SJ. Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine users. Molecular Psychiatry. 5: 664-72. PMID 11126397 DOI: 10.1038/Sj.Mp.4000760  0.701
2000 Kalasinsky KS, Bosy TZ, Schmunk GA, Ang L, Adams VI, Gore SB, Smialek J, Furukawa Y, Guttman M, Kish SJ. Regional distribution of cocaine in postmortem brain of chronic human cocaine users Journal of Forensic Sciences. 45: 1041-1048. PMID 11005179 DOI: 10.1520/Jfs14828J  0.375
2000 Kish SJ, Furukawa Y, Ang L, Vorce SP, Kalasinsky KS. Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user Neurology. 55: 294-296. PMID 10908909 DOI: 10.1212/Wnl.55.2.294  0.439
2000 McLeman ER, Warsh JJ, Ang L, Li PP, Kalasinsky KS, Ross BM, Tong J, Schmunk G, Adams V, Kish SJ. The human nucleus accumbens is highly susceptible to G protein down-regulation by methamphetamine and heroin. Journal of Neurochemistry. 74: 2120-6. PMID 10800957 DOI: 10.1046/J.1471-4159.2000.0742120.X  0.366
2000 Ross BM, Eder K, Moszczynska A, Mamalias N, Lamarche J, Ang L, Pandolfo M, Rouleau G, Kirchgessner M, Kish SJ. Abnormal activity of membrane phospholipid synthetic enzymes in the brain of patients with Friedreich's ataxia and spinocerebellar atrophy type-1. Movement Disorders : Official Journal of the Movement Disorder Society. 15: 294-300. PMID 10752579 DOI: 10.1002/1531-8257(200003)15:2<294::Aid-Mds1013>3.0.Co;2-D  0.724
2000 Furukawa Y, Hornykiewicz O, Fahn S, Kish SJ. Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutation. Neurology. 54: 1193-5. PMID 10720299 DOI: 10.1212/Wnl.54.5.1193  0.372
1999 Fields A, Li PP, Kish SJ, Warsh JJ. Increased cyclic AMP-dependent protein kinase activity in postmortem brain from patients with bipolar affective disorder Journal of Neurochemistry. 73: 1704-1710. PMID 10501218 DOI: 10.1046/J.1471-4159.1999.731704.X  0.396
1999 Furukawa Y, Nygaard TG, Gütlich M, Rajput AH, Pifl C, DiStefano L, Chang LJ, Price K, Shimadzu M, Hornykiewicz O, Haycock JW, Kish SJ. Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia. Neurology. 53: 1032-41. PMID 10496263 DOI: 10.1212/Wnl.53.5.1032  0.437
1999 Furukawa Y, Kish SJ. Dopa-responsive dystonia: Recent advances and remaining issues to be addressed Movement Disorders. 14: 709-715. PMID 10495030 DOI: 10.1002/1531-8257(199909)14:5<709::Aid-Mds1001>3.0.Co;2-T  0.349
1999 Fallbrook A, Turenne SD, Mamalias N, Kish SJ, Ross BM. Phosphatidylcholine and phosphatidylethanolamine metabolites may regulate brain phospholipid catabolism via inhibition of lysophospholipase activity. Brain Research. 834: 207-10. PMID 10407117 DOI: 10.1016/S0006-8993(99)01570-X  0.425
1999 Kish SJ, Kalasinsky KS, Furukawa Y, Guttman M, Lang A, Li L, Adams V, Reiber G, Anthony RA, Anderson W, Smialek J, DiStefano L. Brain choline acetyltransferase activity in chronic, human users of cocaine, methamphetamine, and heroin Molecular Psychiatry. 4: 26-32. PMID 10089005 DOI: 10.1038/Sj.Mp.4000462  0.436
1999 Ross BM, Turenne S, Moszczynska A, Warsh JJ, Kish SJ. Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia. Brain Research. 821: 407-13. PMID 10064828 DOI: 10.1016/S0006-8993(99)01123-3  0.693
1999 Kish SJ, Mastrogiacomo F, Guttman M, Furukawa Y, Taanman JW, Dozić S, Pandolfo M, Lamarche J, DiStefano L, Chang LJ. Decreased brain protein levels of cytochrome oxidase subunits in Alzheimer's disease and in hereditary spinocerebellar ataxia disorders: a nonspecific change? Journal of Neurochemistry. 72: 700-7. PMID 9930743 DOI: 10.1046/J.1471-4159.1999.0720700.X  0.412
1998 Moszczynska A, Turenne S, Kish SJ. Rat striatal levels of the antioxidant glutathione are decreased following binge administration of methamphetamine. Neuroscience Letters. 255: 49-52. PMID 9839724 DOI: 10.1016/S0304-3940(98)00711-3  0.684
1998 Kish SJ, Lopes-Cendes I, Guttman M, Furukawa Y, Pandolfo M, Rouleau GA, Ross BM, Nance M, Schut L, Ang L, DiStefano L. Brain glyceraldehyde-3-phosphate dehydrogenase activity in human trinucleotide repeat disorders. Archives of Neurology. 55: 1299-304. PMID 9779656 DOI: 10.1001/Archneur.55.10.1299  0.366
1998 Eder K, Kish SJ, Kirchgessner M, Ross BM. Brain phospholipids and fatty acids in Friedreich's ataxia and spinocerebellar atrophy type-1. Movement Disorders : Official Journal of the Movement Disorder Society. 13: 813-9. PMID 9756151 DOI: 10.1002/Mds.870130510  0.388
1998 Furukawa Y, Kish SJ. Influence of development and aging on brain biopterin: Implications for dopa-responsive dystonia onset Neurology. 51: 632-634. PMID 9710058 DOI: 10.1212/Wnl.51.2.632  0.331
1998 Morrison LD, Cao XC, Kish SJ. Ornithine decarboxylase in human brain: Influence of aging, regional distribution, and Alzheimer's disease Journal of Neurochemistry. 71: 288-294. PMID 9648877 DOI: 10.1046/J.1471-4159.1998.71010288.X  0.455
1998 Muenter MD, Forno LS, Hornykiewicz O, Kish SJ, Maraganore DM, Caselli RJ, Okazaki H, Howard FM, Snow BJ, Calne DB. Hereditary form of parkinsonism--dementia. Annals of Neurology. 43: 768-81. PMID 9629847 DOI: 10.1002/Ana.410430612  0.381
1998 Ross BM, Moszczynska A, Erlich J, Kish SJ. Low activity of key phospholipid catabolic and anabolic enzymes in human substantia nigra: possible implications for Parkinson's disease. Neuroscience. 83: 791-8. PMID 9483562 DOI: 10.1016/S0306-4522(97)00454-5  0.708
1998 Ross BM, Moszczynska A, Erlich J, Kish SJ. Phospholipid-metabolizing enzymes in Alzheimer's disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A2 activity. Journal of Neurochemistry. 70: 786-93. PMID 9453575 DOI: 10.1046/J.1471-4159.1998.70020786.X  0.705
1997 Bettendorff L, Mastrogiacomo F, Wins P, Kish SJ, Grisar T, Ball MJ. Low thiamine diphosphate levels in brains of patients with frontal lobe degeneration of the non-Alzheimer's type. Journal of Neurochemistry. 69: 2005-10. PMID 9349545 DOI: 10.1046/J.1471-4159.1997.69052005.X  0.382
1997 Guttman M, Burkholder J, Kish SJ, Hussey D, Wilson A, DaSilva J, Houle S. [11C]RTI-32 PET studies of the dopamine transporter in early dopa- naive Parkinson's disease: Implications for the symptomatic threshold Neurology. 48: 1578-1583. PMID 9191769 DOI: 10.1212/Wnl.48.6.1578  0.356
1997 Ross BM, Hudson C, Erlich J, Warsh JJ, Kish SJ. Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2. Archives of General Psychiatry. 54: 487-94. PMID 9152103 DOI: 10.1001/Archpsyc.1997.01830170113015  0.325
1997 Ross BM, Moszczynska A, Blusztajn JK, Sherwin A, Lozano A, Kish SJ. Phospholipid biosynthetic enzymes in human brain. Lipids. 32: 351-8. PMID 9113621 DOI: 10.1007/S11745-997-0044-X  0.687
1997 Kish SJ, Guttman M, Robitaille Y, el-Awar M, Chang LJ, Levey AI. Striatal dopamine nerve terminal markers but not nigral cellularity are reduced in spinocerebellar ataxia type 1. Neurology. 48: 1109-11. PMID 9109912 DOI: 10.1212/Wnl.48.4.1109  0.342
1997 Mathews R, Li PP, Young LT, Kish SJ, Warsh JJ. Increased Gα(q/11) immunoreactivity in postmortem occipital cortex from patients with bipolar affective disorder Biological Psychiatry. 41: 649-656. PMID 9066988 DOI: 10.1016/S0006-3223(96)00113-8  0.306
1997 Rahman S, Li PP, Young LT, Kofman O, Kish SJ, Warsh JJ. Reduced [3H]cyclic AMP binding in postmortem brain from subjects with bipolar affective disorder. Journal of Neurochemistry. 68: 297-304. PMID 8978738 DOI: 10.1046/J.1471-4159.1997.68010297.X  0.401
1996 Przedborski S, Donaldson D, Jakowec M, Kish SJ, Guttman M, Rosoklija G, Hays AP. Brain superoxide dismutase, catalase, and glutathione peroxidase activities in amyotrophic lateral sclerosis. Annals of Neurology. 39: 158-65. PMID 8967746 DOI: 10.1002/Ana.410390204  0.386
1996 Ross BM, Moszczynska A, Kalasinsky K, Kish SJ. Phospholipase A2 activity is selectively decreased in the striatum of chronic cocaine users. Journal of Neurochemistry. 67: 2620-3. PMID 8931499 DOI: 10.1046/J.1471-4159.1996.67062620.X  0.712
1996 Young LT, Asghari V, Li PP, Kish SJ, Fahnestock M, Warsh JJ. Stimulatory G-protein alpha-subunit mRNA levels are not increased in autopsied cerebral cortex from patients with bipolar disorder. Brain Research. Molecular Brain Research. 42: 45-50. PMID 8915579 DOI: 10.1016/S0169-328X(96)00112-X  0.325
1996 Bettendorff L, Mastrogiacomo F, LaMarche J, Dožić S, Kish SJ. Brain levels of thiamine and its phosphate esters in Friedreich's ataxia and spinocerebellar ataxia type 1 Movement Disorders. 11: 437-439. PMID 8813226 DOI: 10.1002/Mds.870110415  0.436
1996 Wilson JM, Levey AI, Rajput A, Ang L, Guttman M, Shannak K, Niznik HB, Hornykiewicz O, Pifl C, Kish SJ. Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease. Neurology. 47: 718-26. PMID 8797470 DOI: 10.1212/Wnl.47.3.718  0.348
1996 Lopes-Cendes I, Maciel P, Kish S, Gaspar C, Robitaille Y, Clark HB, Koeppen AH, Nance M, Schut L, Silveira I, Coutinho P, Sequeiros J, Rouleau GA. Somatic mosaicism in the central nervous system in spinocerebellar ataxia type 1 and Machado-Joseph disease. Annals of Neurology. 40: 199-206. PMID 8773601 DOI: 10.1002/Ana.410400211  0.346
1996 Morrison LD, Smith DD, Kish SJ. Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease. Journal of Neurochemistry. 67: 1328-31. PMID 8752143 DOI: 10.1046/J.1471-4159.1996.67031328.X  0.373
1996 Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nature Medicine. 2: 699-703. PMID 8640565 DOI: 10.1038/Nm0696-699  0.37
1996 Jope RS, Song L, Li PP, Young LT, Kish SJ, Pacheco MA, Warsh JJ. The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain Journal of Neurochemistry. 66: 2402-2409. PMID 8632163 DOI: 10.1046/J.1471-4159.1996.66062402.X  0.367
1996 Wilson JM, Kish SJ. The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat Journal of Neuroscience. 16: 3507-3510. PMID 8627383 DOI: 10.1523/Jneurosci.16-10-03507.1996  0.398
1996 Mastrogiacomo F, Lindsay JG, Bettendorff L, Rice J, Kish SJ. Brain protein and α-ketoglutarate dehydrogenase complex activity in Alzheimer's disease Annals of Neurology. 39: 592-598. PMID 8619544 DOI: 10.1002/Ana.410390508  0.382
1996 Mastrogiacomo F, Bettendorff L, Grisar T, Kish SJ. Brain thiamine, its phosphate esters, and its metabolizing enzymes in Alzheimer's disease Annals of Neurology. 39: 585-591. PMID 8619543 DOI: 10.1002/Ana.410390507  0.381
1996 Bettendorff L, Mastrogiacomo F, Kish SJ, Grisar T. Thiamine, thiamine phosphates, and their metabolizing enzymes in human brain Journal of Neurochemistry. 66: 250-258. PMID 8522961 DOI: 10.1046/J.1471-4159.1996.66010250.X  0.405
1995 Robitaille Y, Schut L, Kish SJ. Structural and immunocytochemical features of olivopontocerebellar atrophy caused by the spinocerebellar ataxia type 1 (SCA-1) mutation define a unique phenotype. Acta Neuropathologica. 90: 572-81. PMID 8615077 DOI: 10.1007/Bf00318569  0.332
1995 Ross BM, Sherwin AL, Kish SJ. Multiple forms of the enzyme glycerophosphodiesterase are present in human brain. Lipids. 30: 1075-81. PMID 8614297 DOI: 10.1007/Bf02536607  0.391
1995 Morrison LD, Kish SJ. Brain polyamine levels are altered in Alzheimer's disease Neuroscience Letters. 197: 5-8. PMID 8545054 DOI: 10.1016/0304-3940(95)11881-V  0.422
1995 Zhong XH, Haycock JW, Shannak K, Robitaille Y, Fratkin J, Koeppen AH, Hornykiewicz O, Kish SJ. Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 10-7. PMID 7885342 DOI: 10.1002/Mds.870100104  0.375
1995 Ross BM, Kim DK, Bonventre JV, Kish SJ. Characterization of a novel phospholipase A2 activity in human brain. Journal of Neurochemistry. 64: 2213-21. PMID 7722506 DOI: 10.1046/J.1471-4159.1995.64052213.X  0.391
1995 Morrison LD, Becker L, Ang LC, Kish SJ. Polyamines in human brain: regional distribution and influence of aging. Journal of Neurochemistry. 65: 636-42. PMID 7616219 DOI: 10.1046/J.1471-4159.1995.65020636.X  0.416
1994 Morrison LD, Sherwin AL, Carmant L, Kish SJ. Activity of S-adenosylmethionine decarboxylase, a key regulatory enzyme in polyamine biosynthesis, is increased in epileptogenic human cortex. Archives of Neurology. 51: 581-4. PMID 8198469 DOI: 10.1001/Archneur.1994.00540180059014  0.332
1994 Wilson JM, Nobrega JN, Carroll ME, Niznik HB, Shannak K, Lac ST, Pristupa ZB, Dixon LM, Kish SJ. Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 2966-79. PMID 8182452 DOI: 10.1523/Jneurosci.14-05-02966.1994  0.356
1994 Shannak K, Rajput A, Rozdilsky B, Kish S, Gilbert J, Hornykiewicz O. Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects. Brain Research. 639: 33-41. PMID 8180836 DOI: 10.1016/0006-8993(94)91761-2  0.428
1994 Joffe RT, Nobrega JN, Kish SJ, Calvo R, Dixon LM, Wilson JM, Morreale de Escobar G. Regional thyroid hormone levels in rat brain Psychoneuroendocrinology. 19: 773-777. PMID 7991764 DOI: 10.1016/0306-4530(94)90024-8  0.341
1994 Ross BM, Kish SJ. Characterization of lysophospholipid metabolizing enzymes in human brain. Journal of Neurochemistry. 63: 1839-48. PMID 7931340 DOI: 10.1046/J.1471-4159.1994.63051839.X  0.391
1994 Kish SJ, Chang LJ, Dixon LM, Robitaille Y, DiStefano L. Cerebellar glutamate metabolizing enzymes in spinocerebellar ataxia type I. Metabolic Brain Disease. 9: 97-103. PMID 7914669 DOI: 10.1007/Bf01996077  0.355
1994 Young LT, Li PP, Kish SJ, Warsh JJ. Cerebral cortex β-adrenoceptor binding in bipolar affective disorder Journal of Affective Disorders. 30: 89-92. PMID 7911133 DOI: 10.1016/0165-0327(94)90035-3  0.303
1994 Mastrogiacomo F, Kish SJ. Cerebellar α-ketoglutarate dehydrogenase activity is reduced in spinocerebellar ataxia type 1 Annals of Neurology. 35: 624-626. PMID 7910005 DOI: 10.1002/Ana.410350519  0.365
1994 Rajput AH, Gibb WR, Zhong XH, Shannak KS, Kish S, Chang LG, Hornykiewicz O. Dopa-responsive dystonia: pathological and biochemical observations in a case. Annals of Neurology. 35: 396-402. PMID 7908789 DOI: 10.1002/Ana.410350405  0.39
1994 Wilson JM, Carroll ME, Lac ST, DiStefano LM, Kish SJ. Choline acetyltransferase activity is reduced in rat nucleus accumbens after unlimited access to self-administration of cocaine Neuroscience Letters. 180: 29-32. PMID 7877755 DOI: 10.1016/0304-3940(94)90906-7  0.321
1994 Wilson JM, Nobrega J, Corrigall WA, Coen KM, Shannak K, Kish SJ. Amygdala dopamine levels are markedly elevated after self- but not passive-administration of cocaine Brain Research. 668: 39-45. PMID 7704616 DOI: 10.1016/0006-8993(94)90508-8  0.36
1994 Young LT, Warsh JJ, Kish SJ, Shannak K, Hornykeiwicz O. Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder Biological Psychiatry. 35: 121-127. PMID 7513191 DOI: 10.1016/0006-3223(94)91201-7  0.377
1993 Young LT, Li PP, Kish SJ, Siu KP, Kamble A, Hornykiewicz O, Warsh JJ. Cerebral cortex Gs alpha protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. Journal of Neurochemistry. 61: 890-8. PMID 8395565 DOI: 10.1111/J.1471-4159.1993.Tb03600.X  0.341
1993 Trevor Young L, Li PP, Siu KP, Kish SJ, Warsh JJ. Regional distribution of guanine nucleotide binding proteins (Gs and Gi α) in human brain: correlation with adenylyl cyclase activity Neurochemistry International. 22: 285-291. PMID 8382985 DOI: 10.1016/0197-0186(93)90057-C  0.377
1993 Morrison LD, Bergeron C, Kish SJ. Brain S-adenosylmethionine decarboxylase activity is increased in Alzheimer's disease Neuroscience Letters. 154: 141-144. PMID 8361629 DOI: 10.1016/0304-3940(93)90191-M  0.442
1993 Morrison LD, Becker L, Kish SJ. S-adenosylmethionine decarboxylase in human brain. Regional distribution and influence of aging Developmental Brain Research. 73: 237-241. PMID 8353934 DOI: 10.1016/0165-3806(93)90143-X  0.441
1993 Nitsch RM, Blusztajn JK, Doyle FM, Robitaille Y, Wurtman RJ, Growdon JH, Kish SJ. Phospholipid metabolite levels are altered in cerebral cortex of patients with dominantly inherited olivopontocerebellar atrophy. Neuroscience Letters. 161: 191-4. PMID 8272265 DOI: 10.1016/0304-3940(93)90291-R  0.395
1993 Mastrogiacomo F, Bergeron C, Kish SJ. Brain α-ketoglutarate dehydrogenase complex activity in Alzheimer's disease Journal of Neurochemistry. 61: 2007-2014. PMID 8245957 DOI: 10.1111/J.1471-4159.1993.Tb07436.X  0.398
1992 Kish SJ, Shannak K, Rajput A, Deck JH, Hornykiewicz O. Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease. Journal of Neurochemistry. 58: 642-8. PMID 1729408 DOI: 10.1111/J.1471-4159.1992.Tb09766.X  0.39
1992 Wilson JM, Nobrega JN, Corrigall W, Shannak K, Deck JHN, Kish SJ. Influence of chronic cocaine on monoamine neurotransmitters in human brain and animal model: Preliminary observations Annals of the New York Academy of Sciences. 654: 461-463. PMID 1632604 DOI: 10.1111/J.1749-6632.1992.Tb25999.X  0.363
1992 Kish SJ, Mamelak M, Slimovitch C, Dixon LM, Lewis A, Shannak K, DiStefano L, Chang LJ, Hornykiewicz O. Brain neurotransmitter changes in human narcolepsy. Neurology. 42: 229-34. PMID 1370862 DOI: 10.1212/Wnl.42.1.229  0.447
1992 Kish SJ, Robitaille Y, el-Awar M, Clark B, Schut L, Ball MJ, Young LT, Currier R, Shannak K. Striatal monoamine neurotransmitters and metabolites in dominantly inherited olivopontocerebellar atrophy. Neurology. 42: 1573-7. PMID 1353622 DOI: 10.1212/Wnl.42.8.1573  0.396
1992 Kish SJ, Bergeron C, Rajput A, Dozic S, Mastrogiacomo F, Chang LJ, Wilson JM, DiStefano LM, Nobrega JN. Brain cytochrome oxidase in Alzheimer's disease. Journal of Neurochemistry. 59: 776-9. PMID 1321237 DOI: 10.1111/J.1471-4159.1992.Tb09439.X  0.431
1992 Petrasek JS, Nobrega JN, Kish SJ, Burnham WM. Autoradiographic analysis of [35S]TBPS binding in entorhinal cortex-kindled rat brains. Brain Research. 570: 167-72. PMID 1319792 DOI: 10.1016/0006-8993(92)90578-W  0.344
1992 Kish SJ, Robitaille Y, Schut L, el-Awar M, Ball MJ, Shannak K. Normal serotonin but elevated 5-hydroxyindoleacetic acid concentration in cerebellar cortex of patients with dominantly-inherited olivopontocerebellar atrophy. Neuroscience Letters. 144: 84-6. PMID 1279488 DOI: 10.1016/0304-3940(92)90721-I  0.359
1991 Young LT, Li PP, Kish SJ, Siu KP, Warsh JJ. Postmortem cerebral cortex Gs α-subunit levels are elevated in bipolar affective disorder Brain Research. 553: 323-326. PMID 1933291 DOI: 10.1016/0006-8993(91)90843-K  0.331
1991 el-Awar M, Kish S, Oscar-Berman M, Robitaille Y, Schut L, Freedman M. Selective delayed alternation deficits in dominantly inherited olivopontocerebellar atrophy. Brain and Cognition. 16: 121-9. PMID 1930971 DOI: 10.1016/0278-2626(91)90001-O  0.34
1991 Warsh JJ, Politsky JM, Li PP, Kish SJ, Hornykiewicz O. Reduced striatal [3H]inositol 1,4,5-trisphosphate binding in Huntington's disease. Journal of Neurochemistry. 56: 1417-22. PMID 1825844 DOI: 10.1111/J.1471-4159.1991.Tb11440.X  0.365
1991 Kish SJ, Du F, Parks DA, Robitaille Y, Ball MJ, Schut L, Hornykiewicz O, Schwarcz R. Quinolinic acid catabolism is increased in cerebellum of patients with dominantly inherited olivopontocerebellar atrophy. Annals of Neurology. 29: 100-4. PMID 1825460 DOI: 10.1002/Ana.410290119  0.366
1991 Kish SJ, Wilson JM, Fletcher PJ. The polyamine synthesis inhibitor α-difluoromethylornithine is neuroprotective against N-methyl-D-aspartate-induced brain damage in vivo European Journal of Pharmacology. 209: 101-103. PMID 1814755 DOI: 10.1016/0014-2999(91)90017-K  0.335
1991 Kish SJ, Robitaille Y, el-Awar M, Gilbert J, Deck J, Chang LJ, Schut L. Brain amino acid reductions in one family with chromosome 6p-linked dominantly inherited olivopontocerebellar atrophy. Annals of Neurology. 30: 780-4. PMID 1686387 DOI: 10.1002/Ana.410300606  0.385
1990 Kish SJ, Robitaille Y, Ball M, Gilbert J, Deck JH, Chang LJ, Schut L. Glycerophosphoethanolamine concentration is elevated in brain of patients with dominantly inherited olivopontocerebellar atrophy. Neuroscience Letters. 120: 209-11. PMID 2293106 DOI: 10.1016/0304-3940(90)90040-G  0.41
1990 Nobrega JN, Kish SJ, Burnham WM. Regional brain [3H]muscimol binding in kindled rat brain: a quantitative autoradiographic examination. Epilepsy Research. 6: 102-9. PMID 2167222 DOI: 10.1016/0920-1211(90)90084-9  0.346
1990 Kish SJ, Distefano LM, Dozic S, Robitaille Y, Rajput A, Deck JH, Hornykiewicz O. [3H]vesamicol binding in human brain cholinergic deficiency disorders. Neuroscience Letters. 117: 347-52. PMID 2151294 DOI: 10.1016/0304-3940(90)90689-7  0.402
1990 Kish SJ, Kleinert R, Minauf M, Gilbert J, Walter GF, Slimovitch C, Maurer E, Rezvani Y, Myers R, Hornykiewicz O. Brain neurotransmitter changes in three patients who had a fatal hyperthermia syndrome. The American Journal of Psychiatry. 147: 1358-63. PMID 2133042  0.329
1990 Robitaille Y, Ball M, Schut L, Kish S. THE NIGROSTRIATAL DOPAMINE SYSTEM IN PATIENTS WITH DOMINANTLY-INHERITED OLIVOPONTOCEREBELLAR ATROPHY Journal of Neuropathology and Experimental Neurology. 49: 280. DOI: 10.1097/00005072-199005000-00065  0.35
1990 Kish S, Dozic S, Deck J, Shannak K, Hornykiewicz O. BRAIN NORADRENERGIC CHANGES IN A PATIENT WITH WILSONʼS DISEASE Journal of Neuropathology and Experimental Neurology. 49: 280. DOI: 10.1097/00005072-199005000-00064  0.382
1989 Kish SJ, Robitaille Y, el-Awar M, Deck JH, Simmons J, Schut L, Chang LJ, DiStefano L, Freedman M. Non-Alzheimer-type pattern of brain cholineacetyltransferase reduction in dominantly inherited olivopontocerebellar atrophy. Annals of Neurology. 26: 362-7. PMID 2802535 DOI: 10.1002/Ana.410260309  0.392
1989 Nobrega JN, Kish SJ, Burnham WM. Autoradiographic analysis of benzodiazepine binding in entorhinal-kindled rat brains. Brain Research. 498: 315-22. PMID 2790486 DOI: 10.1016/0006-8993(89)91110-4  0.344
1989 Kish SJ, Li PP, Robitaille Y, Currier R, Gilbert J, Schut L, Warsh JJ. Cerebellar [3H]inositol 1,4,5-trisphosphate binding is markedly decreased in human olivopontocerebellar atrophy. Brain Research. 489: 373-6. PMID 2787192 DOI: 10.1016/0006-8993(89)90874-3  0.335
1989 Kish S, Karlinsky H, Becker L, Gilbert J, Rebbetoy M, Chang LJ, DiStefano L, Hornykiewicz O. Down's syndrome individuals begin life with normal levels of brain cholinergic markers. Journal of Neurochemistry. 52: 1183-7. PMID 2522539 DOI: 10.1111/J.1471-4159.1989.Tb01864.X  0.422
1988 Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. The New England Journal of Medicine. 318: 876-80. PMID 3352672 DOI: 10.1056/Nejm198804073181402  0.394
1988 Young LT, Li PP, Kish SJ, Chiu AS, Warsh JJ. [3H]Inositol 1,4,5-trisphosphate binding in human cerebral cortex Neuroscience Letters. 87: 283-287. PMID 3260018 DOI: 10.1016/0304-3940(88)90462-4  0.32
1988 Kish SJ, Schut L, Simmons J, Gilbert J, Chang LJ, Rebbetoy M. Brain acetylcholinesterase activity is markedly reduced in dominantly-inherited olivopontocerebellar atrophy. Journal of Neurology, Neurosurgery, and Psychiatry. 51: 544-8. PMID 3164041  0.338
1988 Kish SJ, Dixon LM, Burnham WM, Perry TL, Becker L, Cheng J, Chang LJ, Rebbetoy M. Brain neurotransmitters in glycine encephalopathy. Annals of Neurology. 24: 458-61. PMID 2906530 DOI: 10.1002/Ana.410240319  0.362
1988 Gilbert JJ, Kish SJ, Chang LJ, Morito C, Shannak K, Hornykiewicz O. Dementia, parkinsonism, and motor neuron disease: neurochemical and neuropathological correlates. Annals of Neurology. 24: 688-91. PMID 2904794 DOI: 10.1002/Ana.410240518  0.356
1988 Young LT, Kish SJ, Li PP, Warsh JJ. Decreased brain [3H]inositol 1,4,5-trisphosphate binding in Alzheimer's disease Neuroscience Letters. 94: 198-202. PMID 2853852 DOI: 10.1016/0304-3940(88)90295-9  0.365
1988 KARLINSKY H, KISH S, BECKER L, GILBERT J, REBBETOY M, CHANG L, HORNYKIEWICZ O. BRAIN CHOLINEACETYLTRANSFERASE AND ACETYLCHOLINESTERASE ARE NOT REDUCED IN INFANT DOWN??S SYNDROME BRAIN Alzheimer Disease & Associated Disorders. 2: 242. DOI: 10.1097/00002093-198802030-00091  0.355
1987 Perry TL, Yong VW, Godolphin WJ, Sutter M, Hansen S, Kish SJ, Foulks JG, Ito M. Inability to produce a model of dialysis encephalopathy in the rat by aluminum administration. Neurochemical Research. 12: 369-75. PMID 3600963 DOI: 10.1007/Bf00993247  0.367
1987 Kish SJ, Currier RD, Schut L, Perry TL, Morito CL. Brain choline acetyltransferase reduction in dominantly inherited olivopontocerebellar atrophy. Annals of Neurology. 22: 272-5. PMID 3477997 DOI: 10.1002/Ana.410220214  0.431
1987 Kish SJ, Shannak K, Hornykiewicz O. Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum. Annals of Neurology. 22: 386-9. PMID 2445259 DOI: 10.1002/Ana.410220318  0.382
1986 Kish SJ, Morito CL, Hornykiewicz O. Brain glutathione peroxidase in neurodegenerative disorders. Neurochemical Pathology. 4: 23-8. PMID 2940481 DOI: 10.1007/Bf02834296  0.44
1986 Kish SJ, Rajput A, Gilbert J, Rozdilsky B, Chang LJ, Shannak K, Hornykiewicz O. Elevated gamma-aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease: correlation with striatal dopamine loss. Annals of Neurology. 20: 26-31. PMID 2874765 DOI: 10.1002/Ana.410200106  0.384
1986 Hornykiewicz O, Kish SJ, Becker LE, Farley I, Shannak K. Brain neurotransmitters in dystonia musculorum deformans. The New England Journal of Medicine. 315: 347-53. PMID 2426591 DOI: 10.1056/Nejm198608073150602  0.425
1985 Perry TL, Norman MG, Yong VW, Whiting S, Crichton JU, Hansen S, Kish SJ. Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus. Annals of Neurology. 18: 482-9. PMID 4073841 DOI: 10.1002/Ana.410180411  0.383
1985 Kish SJ, Morito C, Hornykiewicz O. Glutathione peroxidase activity in Parkinson's disease brain. Neuroscience Letters. 58: 343-6. PMID 4047494 DOI: 10.1016/0304-3940(85)90078-3  0.457
1985 Sweeney VP, Perry TL, Price JD, Reeve CE, Godolphin WJ, Kish SJ. Brain gamma-aminobutyric acid deficiency in dialysis encephalopathy. Neurology. 35: 180-4. PMID 3969205 DOI: 10.1212/Wnl.35.2.180  0.361
1985 Perry TL, Yong VW, Hansen S, Foulks JG, Kish SJ. Is a circulating neurotoxin involved in the pathogenesis of Huntington's chorea? Journal of the Neurological Sciences. 67: 351-8. PMID 3157785 DOI: 10.1016/0022-510X(85)90160-1  0.313
1985 Kish SJ, Perry TL, Sweeney VP, Hornykiewicz O. Brain gamma-aminobutyric acid and benzodiazepine receptor binding in dialysis encephalopathy. Neuroscience Letters. 58: 241-4. PMID 2995877 DOI: 10.1016/0304-3940(85)90171-5  0.325
1985 Kish SJ, Fox IH, Kapur BM, Lloyd K, Hornykiewicz O. Brain benzodiazepine receptor binding and purine concentration in Lesch-Nyhan syndrome. Brain Research. 336: 117-23. PMID 2988699 DOI: 10.1016/0006-8993(85)90422-6  0.365
1985 Kish SJ, Chang LJ, Mirchandani L, Shannak K, Hornykiewicz O. Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers. Annals of Neurology. 18: 530-6. PMID 2416269 DOI: 10.1002/Ana.410180504  0.47
1985 Perry TL, Yong VW, Kish SJ, Ito M, Foulks JG, Godolphin WJ, Sweeney VP. Neurochemical abnormalities in brains of renal failure patients treated by repeated hemodialysis. Journal of Neurochemistry. 45: 1043-8. PMID 2411864 DOI: 10.1111/J.1471-4159.1985.Tb05521.X  0.427
1985 Kish SJ, Gilbert JJ, Chang LJ, Mirchandani L, Shannak K, Hornykiewicz O. Brain neurotransmitter abnormalities in neuronal intranuclear inclusion body disorder. Annals of Neurology. 17: 405-7. PMID 2408557 DOI: 10.1002/Ana.410170419  0.442
1984 Kish SJ, Shannak KS, Rajput AH, Gilbert JJ, Hornykiewicz O. Cerebellar norepinephrine in patients with Parkinson's disease and control subjects. Archives of Neurology. 41: 612-4. PMID 6721735 DOI: 10.1001/Archneur.1984.04210080020007  0.402
1984 Kish SJ, Shannak KS, Hornykiewicz O. Reduction of noradrenaline in cerebellum of patients with olivopontocerebellar atrophy. Journal of Neurochemistry. 42: 1476-8. PMID 6707646 DOI: 10.1111/J.1471-4159.1984.Tb02813.X  0.33
1984 Perry TL, Kish SJ, Hinton D, Hansen S, Becker LE, Gelfand EW. Neurochemical abnormalities in a patient with ataxia-telangiectasia. Neurology. 34: 187-91. PMID 6320055 DOI: 10.1212/Wnl.34.2.187  0.366
1984 Kish SJ, Perry TL, Hornykiewicz O. Benzodiazepine receptor binding in cerebellar cortex: observations in olivopontocerebellar atrophy. Journal of Neurochemistry. 42: 466-9. PMID 6319600 DOI: 10.1111/J.1471-4159.1984.Tb02700.X  0.306
1984 Hornykiewicz O, Kish SJ. Neurochemical basis of dementia in Parkinson's disease. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 11: 185-90. PMID 6143610 DOI: 10.1017/S0317167100046382  0.388
1984 Niznik HB, Burnham WM, Kish SJ. Benzodiazepine receptor binding following amygdala-kindled convulsions: differing results in washed and unwashed brain membranes. Journal of Neurochemistry. 43: 1732-6. PMID 6092546 DOI: 10.1111/J.1471-4159.1984.Tb06101.X  0.346
1983 Burnham WM, Niznik HB, Okazaki MM, Kish SJ. Binding of [3H]flunitrazepam and [3H]Ro5-4864 to crude homogenates of amygdala-kindled rat brain: two months post-seizure. Brain Research. 279: 359-62. PMID 6315180 DOI: 10.1016/0006-8993(83)90210-X  0.309
1983 Niznik HB, Kish SJ, Burnham WM. Decreased benzodiazepine receptor binding in amygdala-kindled rat brains. Life Sciences. 33: 425-30. PMID 6308374 DOI: 10.1016/0024-3205(83)90790-7  0.347
1983 Kish SJ, Shannak KS, Perry TL, Hornykiewicz O. Neuronal [3H]benzodiazepine binding and levels of GABA, glutamate, and taurine are normal in Huntington's disease cerebellum. Journal of Neurochemistry. 41: 1495-7. PMID 6137518 DOI: 10.1111/J.1471-4159.1983.Tb00852.X  0.308
1981 Perry TL, Kish SJ, Hansen S, Currier RD. Neurotransmitter amino acids in dominantly inherited cerebellar disorders Neurology. 31: 237-242. PMID 6111044 DOI: 10.1212/Wnl.31.3.237  0.349
1979 Perry TL, Kish SJ, Sjaastad O, Gjessing LR, Nesbakken R, Schrader H, Løken AC. Homocarnosinosis: increased content of homocarnosine and deficiency of homocarnosinase in brain. Journal of Neurochemistry. 32: 1637-40. PMID 448356 DOI: 10.1111/J.1471-4159.1979.Tb02273.X  0.428
Low-probability matches (unlikely to be authored by this person)
2014 Payer DE, Behzadi A, Kish SJ, Houle S, Wilson AA, Rusjan PM, Tong J, Selby P, George TP, McCluskey T, Boileau I. Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [11C]-+-PHNO. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 311-8. PMID 23921256 DOI: 10.1038/Npp.2013.192  0.299
1996 Mastrogiacomo F, LaMarche J, Dozić S, Lindsay G, Bettendorff L, Robitaille Y, Schut L, Kish SJ. Immunoreactive levels of alpha-ketoglutarate dehydrogenase subunits in Friedreich's ataxia and spinocerebellar ataxia type 1. Neurodegeneration : a Journal For Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration. 5: 27-33. PMID 8731379 DOI: 10.1006/Neur.1996.0004  0.297
2014 Matthews BA, Kish SJ, Xu X, Boileau I, Rusjan PM, Wilson AA, DiGiacomo D, Houle S, Meyer JH. Greater monoamine oxidase a binding in alcohol dependence. Biological Psychiatry. 75: 756-64. PMID 24269057 DOI: 10.1016/J.Biopsych.2013.10.010  0.297
2014 Rekkas PV, Wilson AA, Lee VW, Yogalingam P, Sacher J, Rusjan P, Houle S, Stewart DE, Kolla NJ, Kish S, Chiuccariello L, Meyer JH. Greater monoamine oxidase a binding in perimenopausal age as measured with carbon 11-labeled harmine positron emission tomography. Jama Psychiatry. 71: 873-9. PMID 24898155 DOI: 10.1001/Jamapsychiatry.2014.250  0.297
1995 Kish SJ, Zhong XH, Hornykiewicz O, Haycock JW. Striatal 3,4-dihydroxyphenylalanine decarboxylase in aging: disparity between postmortem and positron emission tomography studies? Annals of Neurology. 38: 260-4. PMID 7654075 DOI: 10.1002/Ana.410380220  0.297
2004 Kalasinsky KS, Hugel J, Kish SJ. Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA). Journal of Forensic Sciences. 49: 1106-12. PMID 15461119 DOI: 10.1520/Jfs2003401  0.294
2004 Furukawa Y, Filiano JJ, Kish SJ. Amantadine for levodopa-induced choreic dyskinesia in compound heterozygotes for GCH1 mutations. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 1256-8. PMID 15389992 DOI: 10.1002/Mds.20194  0.294
1989 Warsh JJ, Politsky J, Li PP, Kish SJ. Decreased striatal [3H]-IP3 binding in Huntington's disease Biological Psychiatry. 25: A59-A60. DOI: 10.1016/0006-3223(89)91607-7  0.293
1991 Young LT, Warsh JJ, Li PP, Siu KP, Becker L, Gilbert J, Hornykiewicz O, Kish SJ. Maturational and aging effects on guanine nucleotide binding protein immunoreactivity in human brain. Brain Research. Developmental Brain Research. 61: 243-8. PMID 1752042 DOI: 10.1016/0165-3806(91)90137-8  0.291
2014 Chiuccariello L, Houle S, Miler L, Cooke RG, Rusjan PM, Rajkowska G, Levitan RD, Kish SJ, Kolla NJ, Ou X, Wilson AA, Meyer JH. Elevated monoamine oxidase a binding during major depressive episodes is associated with greater severity and reversed neurovegetative symptoms. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 973-80. PMID 24154665 DOI: 10.1038/Npp.2013.297  0.291
2019 Attwells S, Setiawan E, Wilson AA, Rusjan PM, Miler L, Xu C, Hutton C, Husain MI, Kish S, Vasdev N, Houle S, Meyer JH. Replicating predictive serum correlates of greater translocator protein distribution volume in brain. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31683271 DOI: 10.1038/S41386-019-0561-Y  0.29
1993 Kish SJ, Robitaille Y, el-Awar M, Schut L, DiStefano L, Ball MJ, Mazurek MF. Reduced cerebral cortical but elevated striatal concentration of somatostatin-like immunoreactivity in dominantly inherited olivopontocerebellar atrophy. Journal of Neurology, Neurosurgery, and Psychiatry. 56: 1013-5. PMID 8105030 DOI: 10.1136/jnnp.56.9.1013  0.287
1993 Kish SJ, Young T, Li PP, Siu KP, Robitaille Y, Ball MJ, Schut L, Warsh JJ. Elevated stimulatory and reduced inhibitory G protein alpha subunits in cerebellar cortex of patients with dominantly inherited olivopontocerebellar atrophy. Journal of Neurochemistry. 60: 1816-20. PMID 8473899 DOI: 10.1111/J.1471-4159.1993.Tb13408.X  0.287
1998 Warsh J, McLeman E, Li P, Kish S. 49. Reduced nucleus accumbens Gαi immunolabeling in chronic drug users Biological Psychiatry. 43: S15. DOI: 10.1016/S0006-3223(98)90497-8  0.287
2003 Furukawa Y, Guttman M, Wong H, Farrell SA, Furtado S, Kish SJ. Serum prolactin in symptomatic and asymptomatic dopa-responsive dystonia due to a GCH1 mutation. Neurology. 61: 269-70. PMID 12874420 DOI: 10.1212/01.Wnl.0000073983.82532.49  0.286
1994 Kish SJ, el-Awar M, Stuss D, Nobrega J, Currier R, Aita JF, Schut L, Zoghbi HY, Freedman M. Neuropsychological test performance in patients with dominantly inherited spinocerebellar ataxia: relationship to ataxia severity. Neurology. 44: 1738-46. PMID 7936307 DOI: 10.1212/Wnl.44.9.1738  0.285
1999 Reiach JS, Li PP, Warsh JJ, Kish SJ, Young LT. Reduced adenylyl cyclase immunolabeling and activity in postmortem temporal cortex of depressed suicide victims Journal of Affective Disorders. 56: 141-151. PMID 10701471 DOI: 10.1016/S0165-0327(99)00048-8  0.285
2020 Attwells S, Setiawan E, Rusjan PM, Xu C, Hutton C, Rafiei D, Varughese B, Kahn A, Kish SJ, Vasdev N, Houle S, Meyer JH. Translocator Protein Distribution Volume Predicts Reduction of Symptoms During Open-Label Trial of Celecoxib in Major Depressive Disorder. Biological Psychiatry. PMID 32402468 DOI: 10.1016/J.Biopsych.2020.03.007  0.284
1996 Furukawa Y, Shimadzu M, Rajput AH, Shimizu Y, Tagawa T, Mori H, Yokochi M, Narabayashi H, Hornykiewicz O, Mizuno Y, Kish SJ. GTP-cyclohydrolase I gene mutations in hereditary progressive amd dopa-responsive dystonia. Annals of Neurology. 39: 609-17. PMID 8619546 DOI: 10.1002/Ana.410390510  0.283
1988 Kish SJ, el-Awar M, Schut L, Leach L, Oscar-Berman M, Freedman M. Cognitive deficits in olivopontocerebellar atrophy: implications for the cholinergic hypothesis of Alzheimer's dementia. Annals of Neurology. 24: 200-6. PMID 3178175 DOI: 10.1002/Ana.410240205  0.282
1993 Joffe R, Nobrega J, Kish S, Calvo R, Dixon L, Wilson J. Desipramine reduces plasma but not brain thyroxine levels. Biological Psychiatry. 33: 293-4. PMID 8471684 DOI: 10.1016/0006-3223(93)90298-R  0.282
1997 Campuzano V, Montermini L, Lutz Y, Cova L, Hindelang C, Jiralerspong S, Trottier Y, Kish SJ, Faucheux B, Trouillas P, Authier FJ, Dürr A, Mandel JL, Vescovi A, Pandolfo M, et al. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Human Molecular Genetics. 6: 1771-80. PMID 9302253 DOI: 10.1093/Hmg/6.11.1771  0.281
2008 Boileau I, Houle S, Tong J, Rusjan P, Wilkins D, Selby P, Wilson A, Kish S. Increased vesicular monoamine transporter binding during early abstinence from chronic methamphetamine abuse: Preliminary PET/(+)[11C]DTBZ findings Neuroimage. 41: T122. DOI: 10.1016/J.Neuroimage.2008.04.090  0.28
1997 Montermini L, Kish SJ, Jiralerspong S, Lamarche JB, Pandolfo M. Somatic mosaicism for Friedreich's ataxia GAA triplet repeat expansions in the central nervous system. Neurology. 49: 606-10. PMID 9270608 DOI: 10.1212/Wnl.49.2.606  0.278
2018 Setiawan E, Attwells S, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Xu C, Sharma S, Kish S, Houle S, Meyer JH. Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study. The Lancet. Psychiatry. PMID 29496589 DOI: 10.1016/S2215-0366(18)30048-8  0.277
1983 Kish SJ, Perry TL, Hornykiewicz O. Increased GABA receptor binding in dominantly-inherited cerebellar ataxias. Brain Research. 269: 370-3. PMID 6309324 DOI: 10.1016/0006-8993(83)90149-X  0.277
1998 Piccardo P, Dlouhy SR, Lievens PM, Young K, Bird TD, Nochlin D, Dickson DW, Vinters HV, Zimmerman TR, Mackenzie IR, Kish SJ, Ang LC, De Carli C, Pocchiari M, Brown P, et al. Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. Journal of Neuropathology and Experimental Neurology. 57: 979-88. PMID 9786248 DOI: 10.1097/00005072-199810000-00010  0.276
2015 Payer DE, Park MT, Kish SJ, Kolla NJ, Lerch JP, Boileau I, Chakravarty MM. Personality disorder symptomatology is associated with anomalies in striatal and prefrontal morphology. Frontiers in Human Neuroscience. 9: 472. PMID 26379535 DOI: 10.3389/Fnhum.2015.00472  0.276
2005 Ravina B, Eidelberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, Dhawan V, Feigin A, Fahn S, Guttman M, Gwinn-Hardy K, McFarland H, Innis R, Katz RG, Kieburtz K, ... Kish SJ, et al. The role of radiotracer imaging in Parkinson disease. Neurology. 64: 208-15. PMID 15668415 DOI: 10.1212/01.Wnl.0000149403.14458.7F  0.275
2000 Furukawa Y, Kish SJ, Lang AE. Scoliosis in a dopa-responsive dystonia family with a mutation of the GTP cyclohydrolase I gene Neurology. 54: 2187. PMID 10851395 DOI: 10.1212/Wnl.54.11.2187  0.273
1985 Perry TL, Yong VW, Ito M, Jones K, Wall RA, Foulks JG, Wright JM, Kish SJ. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not destroy nigrostriatal neurons in the scorbutic guinea pig. Life Sciences. 36: 1233-8. PMID 2858797 DOI: 10.1016/0024-3205(85)90267-X  0.273
1998 Furukawa Y, Kish SJ, Bebin EM, Jacobson RD, Fryburg JS, Wilson WG, Shimadzu M, Hyland K, Trugman JM. Dystonia with motor delay in compound heterozygotes for GTP-cyclohydrolase I gene mutations. Annals of Neurology. 44: 10-6. PMID 9667588 DOI: 10.1002/Ana.410440107  0.27
1997 Kish SJ. Brain energy metabolizing enzymes in Alzheimer's disease: α-ketoglutarate dehydrogenase complex and cytochrome oxidase Annals of the New York Academy of Sciences. 826: 218-228. PMID 9329693 DOI: 10.1111/j.1749-6632.1997.tb48473.x  0.268
2013 Rusjan PM, Wilson AA, Mizrahi R, Boileau I, Chavez SE, Lobaugh NJ, Kish SJ, Houle S, Tong J. Mapping human brain fatty acid amide hydrolase activity with PET. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 33: 407-14. PMID 23211960 DOI: 10.1038/Jcbfm.2012.180  0.267
1996 Wilson JM, Levey AI, Bergeron C, Kalasinsky K, Ang L, Peretti F, Adams VI, Smialek J, Anderson WR, Shannak K, Deck J, Niznik HB, Kish SJ. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Annals of Neurology. 40: 428-39. PMID 8797532 DOI: 10.1002/ana.410400312  0.266
2001 Furukawa Y, Graf WD, Wong H, Shimadzu M, Kish SJ. Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations. Neurology. 56: 260-3. PMID 11160968 DOI: 10.1212/Wnl.56.2.260  0.265
2015 Zack M, Boileau I, Payer D, Chugani B, Lobo DS, Houle S, Wilson AA, Warsh JJ, Kish SJ. Differential cardiovascular and hypothalamic pituitary response to amphetamine in male pathological gamblers versus healthy controls. Journal of Psychopharmacology (Oxford, England). PMID 26152320 DOI: 10.1177/0269881115592338  0.265
2007 Martin TL, Chiasson DA, Kish SJ. Does hyperthyroidism increase risk of death due to the ingestion of ecstasy? Journal of Forensic Sciences. 52: 951-3. PMID 17524054 DOI: 10.1111/J.1556-4029.2007.00463.X  0.264
1988 Hornykiewicz O, Kish SJ, Becker LE, Farley I, Shannak K. Biochemical evidence for brain neurotransmitter changes in idiopathic torsion dystonia (dystonia musculorum deformans). Advances in Neurology. 50: 157-65. PMID 2456673  0.264
2011 Bacher I, Houle S, Xu X, Zawertailo L, Soliman A, Wilson AA, Selby P, George TP, Sacher J, Miler L, Kish SJ, Rusjan P, Meyer JH. Monoamine oxidase A binding in the prefrontal and anterior cingulate cortices during acute withdrawal from heavy cigarette smoking. Archives of General Psychiatry. 68: 817-26. PMID 21810646 DOI: 10.1001/Archgenpsychiatry.2011.82  0.263
2023 Watling SE, Jagasar S, McCluskey T, Warsh J, Rhind SG, Truong P, Chavez S, Houle S, Tong J, Kish SJ, Boileau I. Imaging oxidative stress in brains of chronic methamphetamine users: A combined 1H-magnetic resonance spectroscopy and peripheral blood biomarker study. Frontiers in Psychiatry. 13: 1070456. PMID 36704729 DOI: 10.3389/fpsyt.2022.1070456  0.26
1995 Ch. Wolters E, Tissingh G, Bergmans PLM, Kuiper MA, Agid Y, Cervera P, Hirsch E, Hornykiewicz O, Kish SJ, Alexander GE, Crutcher MD, Bergman H, Wichmann T, Delong MR, Strick PL, et al. Dopamine agonists in parkinson's disease Neurology. 45: S28-S34. PMID 7715794  0.256
1983 Sperk G, Lassmann H, Baran H, Kish SJ, Seitelberger F, Hornykiewicz O. Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience. 10: 1301-15. PMID 6141539 DOI: 10.1016/0306-4522(83)90113-6  0.256
2017 Sitte HH, Pifl C, Rajput AH, Hörtnagl H, Tong J, Lloyd GK, Kish SJ, Hornykiewicz O. Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: possible functional implications. The European Journal of Neuroscience. 45: 1356. PMID 28523903 DOI: 10.1111/ejn.13573  0.256
2021 Kish SJ, O'Leary G, Mamelak M, McCluskey T, Warsh JJ, Shapiro C, Bies R, Yu Y, Pollock B, Tong J, Boileau I. Does sodium oxybate inhibit brain dopamine release in humans? An exploratory neuroimaging study. Human Psychopharmacology. e2791. PMID 33899252 DOI: 10.1002/hup.2791  0.256
1987 Kish SJ, Robitaille Y. BRAIN CHOLINERGIC CHANGES IN HEREDITARY OLIVOPONTOCEREBELLAR ATROPHY. Journal of Neuropathology and Experimental Neurology. 46: 339. DOI: 10.1097/00005072-198705000-00030  0.256
2012 Callaghan RC, Cunningham JK, Verdichevski M, Sykes J, Jaffer SR, Kish SJ. All-cause mortality among individuals with disorders related to the use of methamphetamine: a comparative cohort study. Drug and Alcohol Dependence. 125: 290-4. PMID 22503689 DOI: 10.1016/J.Drugalcdep.2012.03.004  0.256
2020 Gaudette E, Watling S, Warsh J, McCluskey T, Tong J, Houle S, Rusjan PM, Rhind SG, Bazinet R, Tyndale RF, Richardson JD, Hill MN, Jelty R, Kish S, Boileau I. Endocannabinoid Metabolism in Posttraumatic Stress Disorder: Results From a Neuroimaging Study With the Novel Fatty Acid Amide Hydrolase Probe, [C-11] Curb Biological Psychiatry. 87: S282-S283. DOI: 10.1016/J.Biopsych.2020.02.729  0.255
2004 Furukawa Y, Kish SJ, Fahn S. Dopa-responsive dystonia due to mild tyrosine hydroxylase deficiency. Annals of Neurology. 55: 147-8. PMID 14705130 DOI: 10.1002/Ana.10820  0.255
2017 Rabin RA, Barr MS, Goodman MS, Herman Y, Zakzanis KK, Kish SJ, Kiang M, Remington G, George TP. Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia versus Non-Psychiatric Controls. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28443616 DOI: 10.1038/Npp.2017.85  0.253
1996 Silveira I, Lopes-Cendes I, Kish S, Maciel P, Gaspar C, Coutinho P, Botez MI, Teive H, Arruda W, Steiner CE, Pinto-Júnior W, Maciel JA, Jerin S, Sack G, Andermann E, et al. Frequency of spinocerebellar ataxia type 1, dentatorubropallidoluysian atrophy, and Machado-Joseph disease mutations in a large group of spinocerebellar ataxia patients. Neurology. 46: 214-8. PMID 8559378 DOI: 10.1212/Wnl.46.1.214  0.252
2014 Boileau I, Bloomfield PM, Rusjan P, Mizrahi R, Mufti A, Vitcu I, Kish SJ, Houle S, Wilson AA, Tong J. Whole-body radiation dosimetry of 11C-carbonyl-URB694: a PET tracer for fatty acid amide hydrolase. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1993-7. PMID 25413137 DOI: 10.2967/Jnumed.114.146464  0.252
2018 Mansouri E, Best LM, Le Foll B, Hendershot CS, Tyndale RF, Kish S, Tong J, Boileau I. T76. Involvement of the Endocannabinoid Enzyme Fatty Acid Amide Hydrolase in the Neurobiology of Impulsivity: Positron Emission Tomography Studies With [11C]CURB Biological Psychiatry. 83: S158. DOI: 10.1016/J.Biopsych.2018.02.412  0.251
2013 Kish SJ. The Pathology of Methamphetamine Use in the Human Brain The Effects of Drug Abuse On the Human Nervous System. 203-297. DOI: 10.1016/B978-0-12-418679-8.00008-3  0.249
2018 Callaghan RC, Halliday M, Gatley J, Sykes J, Taylor L, Benny C, Kish SJ. Comparative hazards of acute myocardial infarction among hospitalized patients with methamphetamine- or cocaine-use disorders: A retrospective cohort study. Drug and Alcohol Dependence. 188: 259-265. PMID 29793190 DOI: 10.1016/J.Drugalcdep.2018.03.030  0.243
1986 Barolet AW, Kish SJ, Morris ME. Identification of extrasynaptic binding sites for [3H]GABA in peripheral nerve. Brain Research. 358: 104-9. PMID 3000511 DOI: 10.1016/0006-8993(85)90953-9  0.241
2012 Matthews B, Kish S, Rusjan P, Wilson A, Boileau I, Houle S, Meyer J. P.6.a.002 Monoamine oxidase A binding during acute alcohol withdrawal: a [C]-harmine PET study European Neuropsychopharmacology. 22: S390. DOI: 10.1016/S0924-977X(12)70606-5  0.24
2018 Best LM, Hendershot CS, Samantha J, Tong J, Le Foll B, Houle S, Tyndale RF, Bazinet R, Kish S, Boileau I. S265. Endocannabinoid Metabolism and Alcohol Consumption in Youth: A PET Study With the Fatty Acid Amide Hydrolase Radioligand [11C]CURB Biological Psychiatry. 83: S451. DOI: 10.1016/J.Biopsych.2018.02.1157  0.237
2012 Callaghan RC, Cunningham JK, Allebeck P, Arenovich T, Sajeev G, Remington G, Boileau I, Kish SJ. Methamphetamine use and schizophrenia: a population-based cohort study in California. The American Journal of Psychiatry. 169: 389-96. PMID 22193527 DOI: 10.1176/Appi.Ajp.2011.10070937  0.237
2000 Furukawa Y, Guttman M, Sparagana SP, Trugman JM, Hyland K, Wyatt P, Lang AE, Rouleau GA, Shimadzu M, Kish SJ. Dopa-responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene Annals of Neurology. 47: 517-520. DOI: 10.1002/1531-8249(200004)47:4<517::Aid-Ana17>3.0.Co;2-B  0.237
1998 Furukawa Y, Lang AE, Trugman JM, Bird TD, Hunter A, Sadeh M, Tagawa T, St George-Hyslop PH, Guttman M, Morris LW, Hornykiewicz O, Shimadzu M, Kish SJ. Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia. Neurology. 50: 1015-20. PMID 9566388 DOI: 10.1212/Wnl.50.4.1015  0.232
2019 Gill T, Richardson D, Mohmand Z, Tong J, McCluskey T, Meyer J, Warsh J, Lanius R, Jelty R, Rhind S, Houle S, Kish S, Hutchison M, Boileau I. F37. Is There Astrocyte Pathology in PTSD? Preliminary Findings of a PET Study With the Monoamine Oxidase B Radioligand [11C]SL25.1188 Biological Psychiatry. 85: S226-S227. DOI: 10.1016/J.Biopsych.2019.03.574  0.232
1998 Piccardo P, Kish SJ, Ang LC, Young K, Bugiani O, Tagliavini F, Dlouhy SR, Ghetti B. PRION PROTEIN ISOFORMS IN THE NEW VARIANT OF GERSTMAN-STRÄUSSLER-SCHEINKER DISEASE Q212P Journal of Neuropathology and Experimental Neurology. 57: 518. DOI: 10.1097/00005072-199805000-00214  0.231
2003 Kish SJ. Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease? Advances in Neurology. 91: 39-49. PMID 12442662  0.231
2020 Green D, Kim J, Kish S, Tyndale RF, Hill M, Strafella A, Tong J, McCluskey T, Westwood D, Houle S, Lobaugh NJ, Boileau I. Fatty Acid Amide Hydrolase and Threat Related Amygdala Activity: A Combined Positron Emission Tomography and Magnetic Resonance Imaging Study Biological Psychiatry. 87: S173-S174. DOI: 10.1016/J.Biopsych.2020.02.458  0.231
1986 Coscina DV, Yehuda S, Dixon LM, Kish SJ, Leprohon-Greenwood CE. Learning is improved by a soybean oil diet in rats. Life Sciences. 38: 1789-94. PMID 3702607 DOI: 10.1016/0024-3205(86)90130-X  0.23
2014 Kitami M, Oizumi H, Kish SJ, Furukawa Y. Takotsubo cardiomyopathy associated with lithium intoxication in bipolar disorder: a case report. Journal of Clinical Psychopharmacology. 34: 410-1. PMID 24699038 DOI: 10.1097/Jcp.0B013E3182A95A27  0.227
1998 Young K, Piccardo P, Kish SJ, Ang LC, Dlouhy S, Ghetti B. GERSTMANN-STRÄUSSLER-SCHEINKER DISEASE (GSS) WITH A MUTATION AT PRION PROTEIN (PrP) RESIDUE 212 Journal of Neuropathology and Experimental Neurology. 57: 518. DOI: 10.1097/00005072-199805000-00213  0.227
2008 Kish S. Limiting production of crystal meth Canadian Medical Association Journal. 179: 558-558. DOI: 10.1503/Cmaj.1080092  0.227
1979 Kish SJ, Perry TL, Hansen S. Regional distribution of homocarnosine, homocarnosine-carnosine synthetase and homocarnosinase in human brain Journal of Neurochemistry. 32: 1629-1636. PMID 448355 DOI: 10.1111/j.1471-4159.1979.tb02272.x  0.225
1996 Ma TK, Ang LC, Mamelak M, Kish SJ, Young B, Lewis AJ. Narcolepsy secondary to fourth ventricular subependymoma. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 23: 59-62. PMID 8673965 DOI: 10.1017/S0317167100039202  0.222
1981 Perry TL, Kish SJ, Hansen S, Wright JM, Wall RA, Dunn WL, Bellward GD. Elevation of brain GABA content by chronic low-dosage administration of hydrazine, a metabolite of isoniazid Journal of Neurochemistry. 37: 32-39. PMID 7252511 DOI: 10.1111/j.1471-4159.1981.tb05287.x  0.22
2019 Attwells S, Setiawan E, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Xu C, Sharma S, Kish S, Houle S, Meyer J. F134. Association of Neuroinflammation With Duration of Untreated Major Depressive Disorder Biological Psychiatry. 85: S265. DOI: 10.1016/J.Biopsych.2019.03.671  0.219
1986 Seizinger BR, Liebisch DC, Kish SJ, Arendt RM, Hornykiewicz O, Herz A. Opioid peptides in Huntington's disease: alterations in prodynorphin and proenkephalin system. Brain Research. 378: 405-8. PMID 2873872 DOI: 10.1016/0006-8993(86)90946-7  0.218
2020 Callaghan RC, Sanches M, Kish SJ. Quantity and frequency of cannabis use in relation to cannabis-use disorder and cannabis-related problems. Drug and Alcohol Dependence. 217: 108271. PMID 32977043 DOI: 10.1016/J.Drugalcdep.2020.108271  0.217
1988 Kish SJ, Dixon LM, Sherwin AL. Aspartic acid aminotransferase activity is increased in actively spiking compared with non-spiking human epileptic cortex Journal of Neurology Neurosurgery and Psychiatry. 51: 552-556. PMID 2898010  0.217
2023 Koshimori Y, Cusimano MD, Vieira EL, Rusjan PM, Kish SJ, Vasdev N, Moriguchi S, Boileau I, Chao T, Nasser Z, Husain MI, Faiz K, Braga J, Meyer JH. Astrogliosis marker 11C-SL2511.88 PET in traumatic brain injury with persistent symptoms. Brain : a Journal of Neurology. PMID 37602426 DOI: 10.1093/brain/awad279  0.209
2019 Callaghan RC, Sanches M, Benny C, Stockwell T, Sherk A, Kish SJ. Who consumes most of the cannabis in Canada? Profiles of cannabis consumption by quantity. Drug and Alcohol Dependence. 205: 107587. PMID 31600617 DOI: 10.1016/J.Drugalcdep.2019.107587  0.204
2023 Green DG, Westwood DJ, Kim J, Best LM, Kish SJ, Tyndale RF, McCluskey T, Lobaugh NJ, Boileau I. Fatty acid amide hydrolase levels in brain linked with threat-related amygdala activation. Neuroimage. Reports. 2: 100094. PMID 37235067 DOI: 10.1016/j.ynirp.2022.100094  0.202
1979 Perry TL, Hansen S, Kish SJ. Effects of chronic administration of antipsychotic drugs on GABA and other amino acids in the mesolimbic area of rat brain Life Sciences. 24: 283-288. PMID 34071 DOI: 10.1016/0024-3205(79)90231-5  0.202
2023 Watling SE, Rhind SG, Warsh J, Green D, McCluskey T, Tong J, Truong P, Chavez S, Richardson JD, Kish SJ, Boileau I. Exploring brain glutathione and peripheral blood markers in posttraumatic stress disorder: a combined [1H]MRS and peripheral blood study. Frontiers in Psychiatry. 14: 1195012. PMID 37333909 DOI: 10.3389/fpsyt.2023.1195012  0.194
1981 Perry TL, Hansen S, Kish SJ, MacLean J, Berry K. Rats chronically injected with urine from Huntington's chorea patients do not incur striatal damage Life Sciences. 28: 2869-2874. PMID 6455580 DOI: 10.1016/0024-3205(81)90103-X  0.193
1997 Lopes-Cendes I, Andermann E, Hayes S, Attig E, Bosch S, Wagner M, Andermann F, Gerstenbrand F, Botez M, Teive H, Cardoso F, Jain S, Robitaille Y, Pulst S, Kish S, et al. 1-29-12 Clinical, genetic and molecular studies in spinocerebellar ataxia type 2 Journal of the Neurological Sciences. 150: S41. DOI: 10.1016/S0022-510X(97)85032-0  0.193
1988 Kish SJ, Olivier A, Dubeau F, Robitaille Y, Sherwin AL. Increased activity of choline acetyltransferase and acetylcholinesterase in actively epileptic human cerebral cortex. Epilepsy Research. 2: 227-31. PMID 3197693 DOI: 10.1016/0920-1211(88)90012-5  0.189
1991 KISH S, HORNYKIEWICZ O, SLIMOVITCH C, KLEINERT R, MAURER E, MINAUF M, WALTER GF, GILBERT J, REZVANI A, MYERS R. Dr. Kish and Associates Reply American Journal of Psychiatry. 148: 1412-1412. DOI: 10.1176/Ajp.148.10.1412  0.189
2019 Callaghan RC, Stockwell T, Sherk A, Kish SJ. Response to Manthey, Carr, and Rehm. Drug and Alcohol Dependence. 107739. PMID 31785997 DOI: 10.1016/J.Drugalcdep.2019.107739  0.183
1983 Kish SJ, Sperk G, Hornykiewicz O. Alterations in benzodiazepine and GABA receptor binding in rat brain following systemic injection of kainic acid. Neuropharmacology. 22: 1303-9. PMID 6320037 DOI: 10.1016/0028-3908(83)90204-6  0.18
2021 Gill T, Watling SE, Richardson JD, McCluskey T, Tong J, Meyer JH, Warsh J, Jetly R, Hutchison MG, Rhind SG, Houle S, Vasdev N, Kish SJ, Boileau I. Imaging of astrocytes in posttraumatic stress disorder: A PET study with the monoamine oxidase B radioligand [C]SL25.1188. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 54: 54-61. PMID 34773851 DOI: 10.1016/j.euroneuro.2021.10.006  0.179
2021 Green DGJ, Kim J, Kish SJ, Tyndale RF, Hill MN, Strafella AP, Tong J, McCluskey T, Westwood DJ, Houle S, Lobaugh NJ, Boileau I. Fatty acid amide hydrolase binding is inversely correlated with amygdalar functional connectivity: a combined positron emission tomography and magnetic resonance imaging study in healthy individuals. Journal of Psychiatry & Neuroscience : Jpn. 46: E238-E246. PMID 33729738 DOI: 10.1503/jpn.200010  0.174
2021 Attwells S, Setiawan E, Rusjan PM, Xu C, Kish SJ, Vasdev N, Houle S, Santhirakumar A, Meyer JH. A double-blind placebo-controlled trial of minocycline on translocator protein distribution volume in treatment-resistant major depressive disorder. Translational Psychiatry. 11: 334. PMID 34052828 DOI: 10.1038/s41398-021-01450-3  0.171
2003 Guttman M, Kish SJ, Furukawa Y. Current concepts in the diagnosis and management of Parkinson's disease. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 168: 293-301. PMID 12566335  0.167
1994 Pristupa ZB, Wilson JM, Hoffman BJ, Kish SJ, Niznik HB. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding. Molecular Pharmacology. 45: 125-35. PMID 8302271  0.166
2015 Chiuccariello L, Cooke RG, Miler L, Levitan RD, Baker GB, Kish SJ, Kolla NJ, Rusjan PM, Houle S, Wilson AA, Meyer JH. Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26316187 DOI: 10.1093/ijnp/pyv078  0.145
2023 Watling SE, Gill T, Gaudette EV, Richardson JD, McCluskey T, Tong J, Meyer JH, Warsh J, Jetly R, Hutchison MG, Rhind SG, Houle S, Kish SJ, Boileau I. Investigating TSPO levels in occupation-related posttraumatic stress disorder. Scientific Reports. 13: 4970. PMID 36973385 DOI: 10.1038/s41598-023-31327-y  0.143
1979 Perry TL, Kish SJ, Hansen S. γ-Vinyl GABA: Effects of chronic administration on the metabolism of GABA and other amino compounds in rat brain Journal of Neurochemistry. 32: 1641-1645. PMID 448357 DOI: 10.1111/j.1471-4159.1979.tb02274.x  0.142
2015 Tong J, Ang LC, Williams B, Furukawa Y, Fitzmaurice P, Guttman M, Boileau I, Hornykiewicz O, Kish SJ. Low levels of astroglial markers in Parkinson's disease: Relationship to α-synuclein accumulation Neurobiology of Disease. 82: 243-253. DOI: 10.1016/j.nbd.2015.06.010  0.139
2020 Rajput AH, Kish SJ. Professor Oleh Hornykiewicz, MD (1926-2020): Remembering the Father of the Modern Treatment of Parkinson's Disease and the Man. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32985723 DOI: 10.1002/mds.28317  0.122
2023 Boachie N, Gaudette E, Bazinet RP, Lin L, Tyndale RF, Mansouri E, Huestis MA, Tong J, Le Foll B, Kish SJ, George TP, Boileau I. Circulating Endocannabinoids and N-Acylethanolamines in Individuals with Cannabis Use Disorder-Preliminary Findings. Brain Sciences. 13. PMID 37891745 DOI: 10.3390/brainsci13101375  0.113
2021 Best LM, Wardell JD, Tyndale RF, McPhee MD, Le Foll B, Kish SJ, Boileau I, Hendershot CS. Association of the Fatty Acid Amide Hydrolase C385A Polymorphism with Alcohol Use Severity and Coping Motives in Heavy-drinking Youth. Alcoholism, Clinical and Experimental Research. PMID 33460184 DOI: 10.1111/acer.14552  0.11
2022 Best LM, Hendershot CS, Buckman JF, Jagasar S, McPhee MD, Muzumdar N, Tyndale RF, Houle S, Logan R, Sanches M, Kish SJ, Le Foll B, Boileau I. Association Between Fatty Acid Amide Hydrolase and Alcohol Response Phenotypes: A Positron Emission Tomography Imaging Study With [C]CURB in Heavy-Drinking Youth. Biological Psychiatry. PMID 36868890 DOI: 10.1016/j.biopsych.2022.11.022  0.106
1997 Tatton NA, Kish SJ. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining Neuroscience. 77: 1037-1048. PMID 9130785  0.096
2000 Furukawa Y, Guttman M, Sparagana SP, Trugman JM, Hyland K, Wyatt P, Lang AE, Rouleau GA, Shimadzu M, Kish SJ. Dopa-responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene Annals of Neurology. 47: 517-520. PMID 10762165 DOI: 10.1002/1531-8249(200004)47:4<517::AID-ANA17>3.0.CO;2-B  0.086
2023 Callaghan RC, Sanches M, Vander Heiden J, Kish SJ. Impact of Canada's cannabis legalisation on youth emergency department visits for cannabis-related disorders and poisoning in Ontario and Alberta, 2015-2019. Drug and Alcohol Review. PMID 36908258 DOI: 10.1111/dar.13637  0.085
2023 Braga J, Lepra M, Kish SJ, Rusjan PM, Nasser Z, Verhoeff N, Vasdev N, Bagby M, Boileau I, Husain MI, Kolla N, Garcia A, Chao T, Mizrahi R, Faiz K, et al. Neuroinflammation After COVID-19 With Persistent Depressive and Cognitive Symptoms. Jama Psychiatry. PMID 37256580 DOI: 10.1001/jamapsychiatry.2023.1321  0.084
2023 Callaghan RC, Sanches M, Hathaway A, Asbridge M, Kish SJ. Canada's cannabis legalization and adult crime patterns, 2015-2021: A time series study. Addictive Behaviors. 146: 107813. PMID 37515896 DOI: 10.1016/j.addbeh.2023.107813  0.083
2021 Callaghan RC, Vander Heiden J, Sanches M, Asbridge M, Hathaway A, Kish SJ. Impacts of Canada's cannabis legalization on police-reported crime among youth: early evidence. Addiction (Abingdon, England). PMID 34085338 DOI: 10.1111/add.15535  0.081
1989 Robitaille Y, Lemoine P, Kish SJ. INVOLVEMENT OF THE PEDUNCULO PONTINE TEGMENTAL NUCLEUS IN FAMILIAL OLIVOPONTOCEREBELLAR ATROPHY Journal of Neuropathology and Experimental Neurology. 48: 381. DOI: 10.1097/00005072-198905000-00246  0.078
1975 Fink BR, Aasheim G, Kish SJ, Croley TS. Neurokinetics of lidocaine in the infraorbital nerve of the rat in vivo: Relation to sensory block. Anesthesiology. 42: 731-6. PMID 1130741 DOI: 10.1097/00000542-197506000-00017  0.078
2023 Callaghan RC, Sanches M, Hathaway A, Asbridge M, MacDonald M, Kish SJ. Canada's cannabis legalization and police-reported cannabis-related criminal incidents among youth, 2015-2021. Drug and Alcohol Dependence. 109892. PMID 37183068 DOI: 10.1016/j.drugalcdep.2023.109892  0.077
1998 Furukawa Y, Shimadzu M, Hornykiewicz O, Kish SJ. Molecular and biochemical aspects of hereditary progressive and dopa-responsive dystonia. Advances in Neurology. 78: 267-82. PMID 9750923  0.074
2022 Callaghan RC, Sanches M, Murray RM, Konefal S, Maloney-Hall B, Kish SJ. Associations Between Canada's Cannabis Legalization and Emergency Department Presentations for Transient Cannabis-Induced Psychosis and Schizophrenia Conditions: Ontario and Alberta, 2015-2019. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437211070650. PMID 35019734 DOI: 10.1177/07067437211070650  0.072
1976 Fink BR, Kish SJ. Reversible inhibition of rapid axonal transport in vivo by lidocaine hydrochloride. Anesthesiology. 44: 139-46. PMID 56150 DOI: 10.1097/00000542-197602000-00009  0.072
1975 Fink BR, Kish SJ, Byers MR. Rapid axonal transport in trigeminal nerve of rat. Brain Research. 90: 85-95. PMID 48405 DOI: 10.1016/0006-8993(75)90684-8  0.054
1976 Byers MR, Kish SJ. Delineation of somatic nerve endings in rat teeth by radioautography of axon-transported protein. Journal of Dental Research. 55: 419-25. PMID 1063751 DOI: 10.1177/00220345760550032001  0.046
2021 Callaghan RC, Sanches M, Vander Heiden J, Asbridge M, Stockwell T, Macdonald S, Peterman BH, Kish SJ. Canada's cannabis legalization and drivers' traffic-injury presentations to emergency departments in Ontario and Alberta, 2015-2019. Drug and Alcohol Dependence. 228: 109008. PMID 34508959 DOI: 10.1016/j.drugalcdep.2021.109008  0.046
1983 Kish S, Sharf R, Margalith P. A note on a selective medium for wine yeasts Journal of Applied Bacteriology. 55: 177-179. DOI: 10.1111/j.1365-2672.1983.tb02663.x  0.038
2015 Xu Z, Hu BX, Davis H, Kish S. Numerical study of groundwater flow cycling controlled by seawater/freshwater interaction in a coastal karst aquifer through conduit network using CFPv2. Journal of Contaminant Hydrology. 182: 131-145. PMID 26387032 DOI: 10.1016/J.Jconhyd.2015.09.003  0.032
2009 Faulkner J, Hu BX, Kish S, Hua F. Laboratory analog and numerical study of groundwater flow and solute transport in a karst aquifer with conduit and matrix domains. Journal of Contaminant Hydrology. 110: 34-44. PMID 19767123 DOI: 10.1016/J.Jconhyd.2009.08.004  0.024
1997 Kish SJ, Meyer MD. Developing management systems for statewide transportation planning: Early lessons Transportation Research Record. 66-70.  0.021
2008 Kish S. A question of ethics Canadian Medical Association Journal. 179: 559-559. DOI: 10.1503/cmaj.1080086  0.01
Hide low-probability matches.